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ABSTRACT 
 At its core, addiction is a pathological state of motivation. While motivation itself is an 
adaptive psychological tool, when the motivation to seek out and engage a specific 
pharmacological agent, such as nicotine, or a biologically relevant stimulus, such as highly 
palatable food, exerts undue control over the behavior of an animal, the adaptive tool of 
motivation is transformed into the maladaptive state of addiction. The insulin signaling system 
plays a vital role in motivated behaviors, particularly in food-seeking behavior. The transient 
receptor potential (TRP) channels, meanwhile, are deeply involved in the sensory systems 
necessary for an organism to monitor its environment in order to locate biologically relevant 
stimuli. Here, we explore a role for the insulin signaling system in the locomotor response of 
nematodes to an acute nicotine challenge as well as a role for TRP channels in mediating 
nicotine-approach behavior in these animals. The studies presented here suggest novel models 
for how drugs of abuse can usurp adaptive motivational processes. We demonstrate that 
nematodes with a compromised insulin signaling system respond to an acute nicotine challenge 
as though it were a depressant rather than a stimulant. This effect persists in both genetic and 
pharmacologic manipulations of the insulin signaling system. We also demonstrate that C. 
elegans will chemotax to a source of nicotine and that vanilloid TRP channels are necessary for 
this behavior. The findings from the studies presented here may serve to identify novel 
therapeutic targets for the treatment of nicotine abuse, which is a leading public health concern 
throughout the developed world.  
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Chapter I 
A Brief Overview of Nicotine-Responsive Behavior 
 
 ‘Addiction’ is a term without a strict definition. In a recent review, Wise and Koob 
lament this very fact and its implications in research related to drugs of abuse (Wise and Koob, 
2014). As they point out, clinical experts tasked with establishing diagnostic criteria – such as 
the American Psychological Association, the American Psychiatric Association, and the World 
Health Organization – all fail to offer a scientific definition for ‘addiction’. In fact, between and 
within these august scholarly bodies, heated arguments rage about how an appropriate, 
methodical definition of the term ‘addiction’ should read (Edwards, 2012; Schuckit, 2012). 
Furthermore, the Diagnostic and Statistical Manual of Mental Disorders (DSM) – the metric by 
which clinical diagnoses of psychological and psychiatric disorders are made – largely avoids the 
use of the word ‘addiction’ altogether (Wise and Koob, 2014). In addition to all of this, 
researchers who are largely held to be leaders in the study of drug-related behaviors and the 
physiological effects of drugs of abuse often give wildly different definitions for the term. 
Robinson, for example, each consider most-specifically the shift from volitional to compulsory 
drug-taking behavior to be commensurate with ‘addiction’ (Edwards, 2012). Everitt prefers to 
focus on the impulsivity of drug-taking behavior as a hallmark of ‘addiction’ (Edwards, 2012). 
Koob suggests that ‘addiction’ is best-defined as the relapse to drug-taking in an abstinent animal 
(Belin et al., 2013). Volkow, meanwhile, classifies ‘addiction’ as the effect of adaptations of 
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motivational neural circuits in response to chronic drug exposure (Belin et al., 2013).  Similarly, 
Nestler focuses on epigenetic responses of cells to drugs of abuse while still comfortably using 
the term ‘addiction’ (Belin et al., 2013). This lack of strict definition for the term ‘addiction’ has 
lead both Wise and White (White, 1989; Wise and Koob, 2014), independently, to recall the 
character Humpty Dumpty in Lewis Carroll’s Through the Looking Glass who said: “When I use 
a word, it means just what I choose it to mean – neither more nor less”.   
Perhaps the most versatile definition of ‘addiction’ is that it is a state of pathological 
motivation. Motivation is an adaptive process that allows an organism to garner biologically 
necessary stimuli and avoid potential threats. Food-gathering, mate-seeking, and denning are all 
examples of appetitive motivated behaviors (Roitman et al., 2004), while the avoidance of 
predators and withdrawal from noxious stimuli are examples of aversive motivated behaviors 
(Badrinarayan et al., 2012). In a healthy psychological state, the motivation for each of these 
behaviors is tempered with the internal state of the animal — hunger, thirst, exhaustion — and 
the current environment — proximity to a predator, exposure to elements, availability of 
palatable food or acceptable mate. In addiction-related states, a natural reward — like food or 
sex — or a drug of abuse — such as nicotine, cocaine, or opioids — arrogates the balance among 
these various motivations and foists itself to the forefront at the expense of biological 
imperatives and despite adverse consequences (Koob, 2009b; Parylak et al., 2011; Robinson, 
2004; Robinson and Berridge, 1993; Schulteis and Koob, 1994). It is this persistent, compulsive 
drug-taking in the face of adverse consequences that separates addiction from recreational drug 
use in humans and a number of animal models seeks to capture or explain this aspect of 
addiction (Koob, 2009b; Koob and Le Moal, 2005; Robinson, 2004). Neural pathways mediating 
motivated behaviors are an especially vulnerable point of entry for drugs of abuse in mammals, 
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and chief among these weak spots is the mesolimbic dopamine (DA) system. This system 
extends from the ventral tegmental area (VTA) of the midbrain to forebrain targets such as the 
nucleus accumbens (NAc), the prefrontal cortex (PFC), and the amygdala. (Everitt et al., 1999; 
Fields et al., 2007; Kauer, 2004; Kauer and Malenka, 2007; Koob, 2009a; Margolis et al., 2006; 
Mihov and Hurlemann, 2012; Niehaus et al., 2009; Stamatakis et al., 2014; Yap and Miczek, 
2008). 
 
Introduction to Insulin Signaling in Nicotine-Responsive Behaviors 
The Ventral Tegmentum 
 Often, the VTA and the A10 DA cells are considered synonymously. However, while the 
VTA includes the entirety of the A10 DA region, the VTA is a complicated and heterogeneous 
collection of nuclei (Ikemoto, 2007; Ikemoto and Bonci, 2014; Wise and Koob, 2014). The 
tegmental cellular heterogeneity is laid out in a rostrocaudal gradient and the forebrain targets 
appear to follow this gradient in a lateromedial manner (Ikemoto, 2007; Lammel et al., 2008). 
That is, cells in the medial and caudal part of the VTA send their axons preferentially to medial 
forebrain structures: the medial PFC (mPFC) and, in particular, the medial portion of the NAc 
shell subregion. Meanwhile, laterally and anteriorly situated VTA neurons target more lateral 
forebrain structures: the amygdala and the NAc core and the lateral portion of the NAcs 
(Lammel et al., 2008). In addition, DA transporter mRNA and the dopamine D2 autoreceptor 
expression appears to decrease along this lateromedial gradient, with DA neurons targeting the 
mPFC and the NAcs expressing the lowest levels of DA transporters and D2 autoreceptors. Thus, 
medial DA neurons express the lowest levels of both somatodendritic DA transporters and D2 
receptors as well as the lowest levels of these proteins in the distal axon terminal fields of these 
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neurons (Lammel et al., 2008). This suggests that the DA neurons projecting to the mPFC and 
the NAcs see the least self-regulation. 
 While the DA neurons are arranged in this anteroposterior gradient, the A10 dopamine 
region is largely contained within the posterior aspect of the VTA while the anterior VTA has a 
larger population of GABA and glutamate cells In fact, immunostaining for tyrosine hydroxylase 
(TH) – the rate limiting step in DA biosynthesis – shows enrichment near the parabrachial 
pigmented and paranigral nuclei of the VTA that diminishes in density laterally and caudally 
(Faure et al., 2014; Ikemoto, 2007; Lammel et al., 2008). A similar gradient exists for the GABA 
and glutamate neurons of the VTA. GABA neurons are most prevalent in the anteriolateral 
regions of the ventral tegmentum while glutamate neurons are localized closer to the midline and 
with greater prevalence rostral to the DA neurons (Faure et al., 2014; Ikemoto, 2007; Sanchez-
Catalan et al., 2014).  
In discussing GABAergic nuclei within the VTA, it is important to note the GABA cells 
of the rostromedial tegmental nucleus (RMTg), lie caudal to, and modulate the firing rate of, A10 
dopamine neurons (Bourdy and Barrot, 2012). These RMTg GABA cells express high levels of 
µ-opioid receptors (Jalabert et al., 2011), are subject to endocannabinoid control (Zangen et al., 
2006) and one of their major targets outside the VTA is the lateral hypothalamus (Richardson et 
al., 2014) – a major center for control of feeding behaviors. Both the µ-opioid and the 
cannabinoid receptors act to decrease output from RMTg neurons, which disinhibits the DA 
neurons under their control, while reciprocal glutamate afferents from the lateral hypothalamus 
drive GABA output onto these DA neurons, increasing inhibitory control over them (Bourdy and 
Barrot, 2012; Bourdy et al., 2014; Jalabert et al., 2011; Kaufling et al., 2010). This lateral 
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hypothalamus-ventral tegmentum axis is likely an important circuit, at least in part, for indicating 
post-prandial satiety. This seems especially likely given the role insulin plays within the VTA.  
 
Nicotine, Insulin, and the Ventral Tegmentum 
Insulin receptors are expressed throughout the VTA (Bruijnzeel et al., 2011; Davis et al., 
2010; Daws et al., 2011). On DA neurons, activation of the intracellular insulin signaling 
pathway, through intracerebroventricular (ICV) infusion of the peptide hormone, increases cell-
surface expression of both the DA transporter and the D2 autoreceptor (Figlewicz et al., 1994; 
Schoffelmeer et al., 2011). Moreover, a nine peptide fragment of the insulin β-chain appears to 
increase binding of DA to its transporter (Liu et al., 2001), thus decreasing the activity of 
extracellular dopamine. Furthermore, insulin induces an AMPAR trafficking-independent form 
of long-term depression (LTD) in VTA DA neurons (Grueter et al., 2010; Labouebe et al., 2013). 
That is to say, insulin decreases the output from tegmental DA neurons.  VTA µ-opioid receptor 
activity, meanwhile, is dependent upon insulin response substrate (IRS) and Akt/PKB, which are 
canonical elements of the insulin signaling pathway (Russo et al., 2007). Furthermore, the 
phosphoinositide 3-kinase (PI3K) – another canonical insulin signaling element – is necessary 
for somatodendritic dopamine release within the tegmentum (Daws et al., 2011). 
Insulin is the major hormone responsible of maintaining energy homeostasis (Anthony et 
al., 2006; Boghossian et al., 2009; Bruijnzeel et al., 2011; Davis et al., 2010; Daws et al., 2011; 
Figlewicz et al., 2008) so it is unsurprising this peptide would exert some modicum of regulatory 
control over the mesolimbic DA system that is so crucial in effecting motivated behaviors. 
Nicotine – the exogenous ligand derived from tobacco for which nicotinic acetylcholine 
receptors (nAChR) are named – is also an anorectic agent and these nAChR are enriched 
! 6!
throughout the VTA (Figlewicz et al., 2008; Konner et al., 2011; Labouebe et al., 2013). In 
mammals, nAChR are pentameric proteins consisting of at least one of nine α-subunits (α2-α10) 
and sometimes one or more β-subunits (β2-β4) (Faure et al., 2014). The composition and 
stoichiometry of the subunits can determine a number of functional and pharmacological 
properties of the nAChR. For example, a heteropentamer containing an α4 and β2 subunit, with 
or without other subunits (henceforth, α4β2*), are heavily up-regulated in response to chronic 
nicotine exposure and have a high affinity for a number of nicotinic agonists (Changeux et al., 
1998; Picciotto et al., 1998), while the homopentameric α7 nAChR has a relatively low affinity 
for ACh but rapidly activates and desensitizes once the ligand successfully binds is highly 
permissive of calcium entry (Changeux and Edelstein, 2005). The expression pattern of these 
various nAChR can greatly affect the role of ACh, and the ACh-mimetic nicotine, in influencing 
both DA neuron and GABA neuron activity within the VTA.  DA neuron somata in the ventral 
tegmentum, for example, mostly express receptors containing α4, α5, α6, α7, β2, and β3 
subunits while the axons of these neurons in the forebrain only express receptors containing α4, 
α6, and β2 subunits. GABA neurons in the VTA, on the other hand, mainly express α7 and 
α4β2 receptors but the axon terminals of glutamatergic cortical afferents largely express the α7 
receptor alone, which has a higher affinity for nicotine than it does for ACh (EC50nicotine: 111.3 
µM; EC50ACh: 179.6 µM).  This preference for nicotine over the endogenous ligand persists in 
the α4β2 receptors, as well (EC50nicotine: 5.5 µM; EC50ACh: 68.1 µM) (Changeux and Edelstein, 
2005; Di Chiara, 2000; Faure et al., 2014; Kaufling et al., 2010; Picciotto et al., 1998), which 
partially explains how nicotine is such a potently addictive drug of abuse.  
Spontaneous tegmental DA neuron activity shifts between a basal, tonic activity with 
relatively low frequency of action potential firing (generally not more than 10 Hz) that is 
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dependent upon a pacemaker mechanism (Exley et al., 2008; Exley and Cragg, 2008; Exley et 
al., 2011; Exley et al., 2012) and brief, phasic activity with high frequency bursts of action 
potentials. These phasic bursts are, at least partially, dependent upon acetylcholine, most likely 
from cholinergic afferents from the laterodorsal tegmental nucleus (LDTg), as inactivation of 
this nucleus prevents DA neuron bursting even in the presence of glutamate (Lodge and Grace, 
2006) and the posterior pedunculopontine tegmental nucleus (PPTg), which is necessary for cue-
induced DA release in freely behaving rodents and can induce DA neuron bursting directly 
(Floresco et al., 2003; Pan and Hyland, 2005; Pan et al., 2005). The β2 subunit is necessary for 
setting the permissive state that allows spontaneous DA neuron activity to switch from tonic to 
phasic, as β2-/- mice show only the tonic, low-level pacemaker firing rate dissociated A10 
neurons demonstrate (Maskos et al., 2005). Moreover, GABA neurons within the VTA appear to 
be a necessary regulator of this tonic-to-phasic activity as β2 expression in DA neurons alone 
does not rescue the defect of β2-/- mice but expression of this subunit in GABA neurons alone 
can rescue the phenotype (Avale et al., 2008). Additionally, the α4 subunit appears to be crucial 
for determining the architecture of spontaneous bursting patterns in the A10 neurons. This is 
putatively due to an imbalance between ACh activity directly at the DA neurons and indirectly 
through the GABA neurons (Exley et al., 2011), and the up-regulation of α4* nAChR following 
chronic nicotine exposure (Nashmi et al., 2007) supports this explanation, as one would expect 
prolonged nicotine exposure to require increased inhibitory control from GABAergic neurons to 
dampen the aberrant cholinergic drive on the DA neurons. In addition to cholinergic control of 
spontaneous DA neuron activity, it is likely that nAChR play a vital role in coordinating the 
activity of VTA neuron ensembles (Floresco et al., 2003; Lodge and Grace, 2006; Pan and 
Hyland, 2005; Pan et al., 2005) as subpopulations of these neurons respond differentially to the 
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stimuli with different motivational valence (Lammel et al., 2011; Lammel et al., 2014; Lammel 
et al., 2012; Ungless et al., 2004). That is, some VTA neurons respond preferentially to 
appetitive stimuli while other VTA neurons prefer stimuli with a more aversive character.  
 
The Nucleus Accumbens 
 The NAc, or ventral striatum, is a major limbic target of tegmental dopamine neurons. 
This subcortical structure is divided, anatomically, into the NAc core and the NAc shell 
(Aragona et al., 2008; Aragona et al., 2009; Badrinarayan et al., 2012; Carlezon and Thomas, 
2009; Ikemoto, 2007; Lammel et al., 2008). The shell is a comet-shaped structure with the head 
of the ‘comet’ lying medial to the NAc core and the horn, or lateral aspect, of the shell (tail of the 
‘comet’) wrapping under the inferior aspect of the core (Baldo, 2001). While the core versus 
shell divisions were originally anatomically-derived, there are some functional differences 
between the two subregions. The NAc shell receives DA input from the more medial VTA 
neurons, which are not as enriched in DA transporter and D2 receptors on their axons (Ikemoto, 
2007; Lammel et al., 2008). Consequently, the shell tends to have a higher frequency of 
spontaneous DA release events (‘transients’) than the core subregion (Aragona et al., 2008; 
Aragona et al., 2009; Badrinarayan et al., 2012; Twining et al., 2014; Wheeler et al., 2011). 
Moreover, stimulus-evoked DA events differ between the core and the shell. The dopamine in 
the NAc shell responds preferentially to an unconditioned stimulus, while the NAc core DA 
responses are typically phase-locked to a CS with training (Aragona et al., 2008; Aragona et al., 
2009; Badrinarayan et al., 2012; Day et al., 2007; Day et al., 2006; Roitman et al., 2004; 
Roitman et al., 2008; Twining et al., 2014; Wheeler et al., 2011). Furthermore, the extracellular 
DA of the NAc shell shows a rostrocaudal gradient in the motivational valence of stimuli to 
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which it responds, while NAc core DA does not (Aragona et al., 2008; Badrinarayan et al., 2012; 
Phillips et al., 2003; Robinson et al., 2003). This is likely due to what the DA responses ‘tells’ 
the accumbens about the stimulus. The shell DA seems to encode information about the 
motivational salience of the stimulus, while DA in the NAc core appears to carry information 
about the predictive nature of the stimulus (Aragona et al., 2008; Badrinarayan et al., 2012; 
Loriaux et al., 2011). That is, the NAc core DA levels do not respond to the US because the 
unconditioned properties have no predictive value as they are what the CS is predicting.   
 What the core and shell subregions have in common is their cytoarchitecture. Regardless 
of subregion, the major projection neuron of the NAc are the GABAergic medium spiny neurons 
(MSNs), which are enmeshed in a matrix of GABAergic fast-spiking interneurons (FSIs) and 
cholinergic tonically active neurons (TANs) (Atallah et al., 2014). These TANs are of particular 
interest as they are synaptic targets of GABAergic afferents from the VTA (Chuhma et al., 2014) 
that show firing patterns reminiscent of tegmental extracellular electrophysiology during reward-
learning trials. Namely, the firing pattern of both tegmental neurons and TANs appear to track 
differences in the expected outcome versus the actual outcome of an event or action (Atallah et 
al., 2014). While the tegmental neurons track reward expectation (Mirenowicz and Schultz, 
1996), however, the TANs track performance, becoming increasingly quieter as the animal 
becomes increasingly more proficient at a task, but rebounding when reward contingency and, 
therefore, performance suddenly changes (Atallah et al., 2014). Interestingly, there is evidence to 
suggest that TANs can drive GABA release from midbrain DAergic terminals as a rapid braking 
system for the MSN projections (Pitman et al., 2014). Reciprocally, DAergic terminals induce a 
pause in the tonic activity of the TANs (Atallah et al., 2014). 
 
! 10!
Nicotine, Insulin, and the Nucleus Accumbens 
 While the nAChR α4 and β2 subunits are of particular importance in the VTA, the α6 
and α7 subunits are major players within the NAc. As in the VTA, in the NAc, homomeric α7 
nAChRs are localized largely to the axon terminals of pyramidal cell afferents from the cortex 
(Faure et al., 2014). However, in the NAc α7 receptors seem to be of greater influence due to 
greater expression levels of these proteins (Laviolette et al., 2004; Laviolette and van der Kooy, 
2004) and the activity of both the cholinergic TANs as well as cholinergic afferents from the 
LDTg and PPTg (Laviolette et al., 2002). The α6* nAChR, especially the α6β2*, is necessary 
for mediating the rewarding properties of both nicotine and cocaine (Sanjakdar et al., 2014), 
although it is unclear whether these receptors are expressed on the MSN or FSI cell-types.   
 Again, it is unsurprising that feeding-related peptides would have activity within a 
structure like the NAc that is concerned with predicting when and where food, and other 
motivationally salient stimuli, will be available (Baldo, 2001; Roitman et al., 2004). While many 
of the effects insulin has on the NAc are mediated through alterations in tegmental DA signaling, 
insulin does have activity within the NAc, particularly on DA terminals where it can regulate DA 
transporter action through the IRS/Akt pathway discussed previously (Russo et al., 2007). 
Furthermore, both insulin receptors and dopamine receptors – particularly the D2 receptor – 
converge on Akt/PKB (Sugano et al., 2006), which suggests the possibility of crosstalk between 
these two intracellular signaling pathways in NAc MSNs. Concurrently, amylin – a gut peptide 
released with insulin – has a specific action in the NAc. Namely, intra-NAc amylin infusions 
shut down the motivation to feed (Baldo, 2001). Furthermore, while µ-opioid receptor activation 
in the NAc can induce gluttonous feeding behaviors, amylin receptor activity blocks this 
pharmacologically-driven feeding behavior (Baisley and Baldo, 2014).  
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Nicotine, Insulin, and Nematodes 
 While the VTA and NAc are entry points for drugs of abuse to usurp mammalian neural 
circuits, a command interneuron, known as AVA, is a point of vulnerability for the soil 
nematode, Caenorhabditis elegans, when it is exposed to nicotine concentrations high enough to 
diffuse through the cuticle. Nicotine-exposed worms increase their crawl-speed acutely; they 
adapt to prolonged nicotine treatment; they show withdrawal behaviors when removed from a 
nicotine-rich environment; and, they show sensitization to repeated nicotine administration. 
These early studies provided evidence of a clear role for the AVA command interneuron, and its 
nAChR and TRPC Channels in these behaviors (Feng et al., 2006). Another research group 
recently probed whether C. elegans nicotine chemotaxis can be used as a nematode model of 
motivated behaviors (Sellings et al., 2013). Their studies showed worms will chemotax up a 
nicotine concentration gradient towards a point-source of the drug placed directly onto the 
medium and worms will show a place preference for a non-paralyzing concentration of nicotine 
(50 µM) versus vehicle as well as conditioning a preference for butanone [a normally repellant 
odorant (Bargmann, 2006)] after it was paired with nicotine. This van der Kooy group also 
identified two nACh receptors (ACR-5, ACR-15) and two DOPamine receptors (DOP-1, DOP-2) 
as critical for nematode nicotine approach behavior in this paradigm (Sellings et al., 2013). 
These researchers posit a complicated model to explain this nicotine approach behavior in which 
nicotine diffuses through the cuticle to act as ligand at ACR-15 receptors expressed on the AVA 
command interneuron. Through gap junctions, this AVA depolarization activates the 
mechanosensory neural circuits that feed back onto a second command interneuron, AVB, which 
then releases ACh onto the B-type, cholinergic motor neurons, which express ACR-5 receptors. 
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This pathway, they suggest, then induces locomotion towards the point-source of nicotine 
(Sellings et al., 2013). Consequently, the AVA command interneuron may serve as a nematode 
analog to the VTA and NAc in mammals as a point of vulnerability in nicotine-responsive 
behaviors.  
 Nicotine has numerous effects on systems regulating mammalian energy homeostasis. 
For example, chronic nicotine users are more susceptible to insulin insensitivity and the 
adipocytes of these users may be insulin resistant long before other signs or symptoms of insulin 
insensitivity present clinically (Xu et al., 2012). Nicotine down-regulates some feeding-related 
peptides, such as neuropeptide Y (NPY) and agouti-related peptide (AgRP), but up-regulates 
others, like cocaine-and-amphetamine-response transcript (CART) and α-melanocyte stimulating 
hormone (α-MSH) (Dandekar et al., 2011; Fornari et al., 2007; Kramer et al., 2007a; Kramer et 
al., 2007b). In fact, α-MSH acting at the melanocortin 4 receptor (MC4R) — defects in which 
cause an autosomal-dominant form of obesity (Pardini et al., 2006) — appears to mediate, at 
least in part, the orexigenic effects of chronic nicotine withdrawal in abstinent users (Bellinger et 
al., 2010). In addition to these feeding peptides, nicotine also stimulates the cytokines tumor 
necrotic factor-α (TNFα) and interleukin-6 (IL-6), which affect appetite and lipid metabolism 
(Wang et al., 2011). IL-6, acting independently of TNF, serves as a myokine that may influence 
energy homeostasis and metabolism of muscle cells and brown adipocytes (Pedersen, 2006; 
Pedersen and Fischer, 2007), although it is unclear whether nicotine works through this myocyte-
derived IL-6. It is clear, however, that nicotine can suppress energy release from brown 
adipocytes (Gao et al., 2008; Gochberg-Sarver et al., 2012; Yoshida et al., 1999). Furthermore, 
nicotine diminishes the levels of circulating adiponectin, a peptide hormone that may suppress a 
number of metabolic disorders including type II diabetes, NFALD, obesity, and a host of others 
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(Inoue et al., 2011; Won et al., 2014). Importantly, these metabolic effects of nicotine, especially 
its contributions to glucose intolerance and insulin resistance, occur regardless of whether the 
nicotine exposure is through an active (smoking a cigarette) or passive (second-hand smoke) 
route (USPHS, 2008). 
In C. elegans, the gene daf-2 (abnormal DAuer Formation) encodes an ortholog of the 
receptor tyrosine kinases of the insulin receptor (IIS) family. The mammalian insulin receptor, 
insulin-like growth factor receptors (IGF1R and IGF2R), and insulin receptor-related receptor 
(INSRR) share close to 30% sequence homology with the DAF-2 receptor (Murphy and Hu, 
2013). While only a single IIS ortholog exists in C. elegans, daf-2 has splice variants for three 
distinct isoforms, each with its own putative expression pattern and specialized functions (Ohno 
et al., 2014). Unfortunately, we know very little about the DAF-2b and DAF-2c isoforms to date. 
However, DAF-2c seems to be most similar to DAF-2a, appears to be solely expressed in 
neurons, and is orthologous to the B isoform of the mammalian insulin receptor. The DAF-2b 
isoform, on the other hand, is most similar to IGFR but is also enriched in neurons (Murphy and 
Hu, 2013). In mammals, and likely in nematodes, IIS are an α2/β2 heterotetramer with α-subunit 
ligand-binding domains and β-subunit kinase domains (Ohno et al., 2014). Upon ligand binding, 
the kinase domains recruits an IRS protein, IST-1 (Insulin response SubsTrate homolog) that, 
through an adaptor protein, activates PI3K - the nematode homolog of which is AGE-1 (AGEing 
alteration) (Murphy and Hu, 2013). AGE-1/PI3K phosphorylates the 3’ position on the inositol 
ring of phosphoinositide (PIP3), thereby increasing PIP3-dependent signaling complex activity. 
Thus, AGE-1/PI3K works in direct opposition to DAF-18, a phosphatase and tensin (PTEN) 
homolog, that dephosphorylates PIP3 (Murphy and Hu, 2013).  
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 A result of PIP3 activity is the recruitment and phosphorylation of phosphoinositide-
dependent kinase (PDK) - whose C. elegans homolog is the conveniently named, PDK-1 
(Murphy and Hu, 2013). In turn, PDK-1 phosphorylates the nematode homologs of Akt/PKB, 
AKT-1 and AKT-2 (Murphy and Hu, 2013). These Akt homologs, however, are most similar to 
mammalian AKT2 than AKT1 (Murphy and Hu, 2013). Together, they act semi-redundantly in 
the regulation, through phosphorylation, of several target proteins or protein complexes. Among 
these are the Ras cell survival pathway, rictor/mTORC2 complex, and the FoxO family of 
forkhead box transcription factors, the only ortholog of which in C. elegans is DAF-16 (Murphy 
and Hu, 2013). Phosphorylation of DAF-16/FoxO prevents the translocation of this transcription 
factor to the nucleus, sequestering it to the cytosol (Murphy and Hu, 2013). Importantly, loss of 
function mutations in daf-16 suppress the phenotypes seen when the function of any kinase 
upstream of the transcription factor is disrupted (Murphy and Hu, 2013), which implies DAF-
16/FoxO activity is required for these phenotypes dependent upon insulin signaling. Fig 1.1 
summarizes this kinase cascade.   
 
Transient Receptor Potential Channels in Drug-Related Behaviors 
Transient Receptor Potential Channels in Drug Dependence 
In humans, drugs of abuse target different neurotransmitter systems, but they all converge 
on midbrain DA neurons in the VTA or in the projections of these neurons to forebrain 
structures, such as the amygdala, striatum, especially the nucleus accumbens, and prefrontal 
cortex (Lammel et al., 2008). Some drugs have a straightforward action on DA signaling, such as 
cocaine and amphetamine, which act as indirect monoamine agonists by blocking the clearance 
of DA from the parenchyma, thereby prolonging the activity of the transmitter at its cognate 
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receptors (Porter-Stransky et al., 2011; Stuber et al., 2005). The action of other drugs, such as 
nicotine and ethanol, seems to be more complex. These drugs mainly interact with GPCRs, 
monoamine transporters, or alter the function of ion channels to modulate DA levels in appetitive 
motivation (Luscher and Ungless, 2006), learning (Jones et al., 2010), and executive control 
circuits in the brain (Koob, 2010). An increasing number of studies suggest that transient 
receptor potential (TRP) channels are important targets of second messengers in these 
mammalian neural circuits that become compromised in addiction. 
TRP channels are perhaps best known for their role as one of the prominent protein 
superfamilies modulating sensory signaling pathways (Montell, 2001, 2005; Nilius and 
Owsianik, 2011). The members of the TRP channel superfamily have six transmembrane 
domains that form homo- or heterotetrameric cation channels, with strong homology to its 
founding member, the Drosophila protein, TRP. The TRP superfamily includes seven 
subfamilies: canonical (TRPC), vanilloid (TRPV), ankyrin (TRPA), melastatin (TRPM), 
polycystin (TRPP), MucoLupin (TRPML) and NompC-like (TRPN). These functionally 
divergent, non-selective cation channels are conserved from nematodes to vertebrates and are 
considered to be coincidence detectors and convergent signal integrators (Kang et al., 2010; Xiao 
and Xu, 2009) (for summary, see Fig 1.2). The diverse activation mechanisms and biophysical 
properties of different TRP family members allow these proteins to modulate complex behaviors, 
especially behaviors related to drug-seeking and drug-taking. (Cavalie, 2007; Gulbransen et al., 
2008; Oliveira-Maia et al., 2009). Here, we outline the emerging role for TRP channels in drug 
dependence. 
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Canonical TRP (TRPC) channels in drug dependence 
Of the TRP channel superfamily, TRPC channels are most closely homologous to the 
Drosophila TRP, the founding member of the TRP channel superfamily (Montell and Rubin, 
1989). These channels are mainly activated in a phospholipase C (PLC)-dependent manner 
(Venkatachalam and Montell, 2007). In humans, there are six TRPC channels that form homo- 
and heterotetramers (Venkatachalam and Montell, 2007). These are multi-functional channels 
implicated in the regulation of diverse physiological functions, such as kidney filtration, 
acrosomal reaction, vascular tone and pheromone recognition (Nilius and Owsianik, 2011). 
Specific to drug dependence, genome-wide association (GWA) studies between smoker and non-
smoker cohorts implicate TRPC channels in nicotine addiction. These studies particularly 
identify the TRPC7 channel among other novel genes that were previously not associated with 
addiction (Bierut et al., 2007; Lessov-Schlaggar et al., 2008). TRPC7 is enriched in brain tissue, 
especially in striatal regions where it impinges on neurons imperative for behavioral responses to 
drugs of abuse (Numaga et al., 2007). Interestingly, another GWA study implicates TRPC4 in 
drug dependence, based on comparisons between European-American and African-American 
polysubstance abusers or non-abusing controls (Uhl et al., 2008). TRPC4 is important for the 
vasorelaxation of arteries and neurotransmitter release from thalamic dendrites (Cavalie, 2007).  
While direct evidence demonstrating a role for mammalian TRPC channels in drug 
addiction is still lacking, rodent fear-learning studies reveal a clear role for TRPC5 in forming 
associations between an unconditioned stimulus (US) and a conditioned stimulus (CS) in the 
amygdala (Riccio et al., 2009). The amygdala is critical for learning associations between the CS 
and US (Schafe et al., 2005), and human drug users show event-related potentials (ERP) viewing 
drug-related paraphernalia similar to the ERPs they show when viewing positive emotional 
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stimuli (Dunning et al., 2011). In a functional MRI study, the amygdala showed decreased focal 
signal in response to an unpredicted cocaine administration (Breiter et al., 1997).  
Cocaine modulates intrinsic plasticity of accumbens neurons (Kourrich et al., 2007) and 
affects metabotropic glutamate receptor (mGluR)-dependent synaptic plasticity in the nucleus 
accumbens (Huang et al., 2011) and prefrontal cortex (Huang et al., 2007). TRPC1 is an mGluR 
target in cerebellar Purkinjie cells (Kim et al., 2003), while both TRPC3 and TRPC7 are known 
targets of mGluR activity in striatal cholinergic interneurons (Berg et al., 2007). Moreover, 
TRPC5 mRNA is located within the shell subregion of the nucleus accumbens (Fowler et al., 
2007), which is preferentially activated by cocaine (Aragona et al., 2008) and is particularly 
responsive to the unconditioned aspects of stimuli (Wheeler et al., 2011). It will be interesting to 
test whether TRPC channels have a role in the motivational, learning and executive control 
circuits drugs of abuse undermine when recreational drug users succumb to addiction. 
The most direct evidence supporting a role for TRPC channels in drug-related behaviors 
comes from the nematode Caenorhabditis elegans. C. elegans requires the TRPC homologues 
TRP-1 and TRP-2 for nicotine-dependent behaviors (Feng et al., 2006). The C. elegans genome 
encodes members of all the seven TRP channel subfamilies (Xiao and Xu, 2009). Most of these 
members are involved in various chemosensory or mechanosensory pathways, either as primary 
sensors or as signal transducers or amplifiers (Xiao and Xu, 2009). There are three TRPC 
subfamily members in C. elegans: TRP-1, TRP-2 and TRP-3. While TRP-3 is enriched in sperm, 
the neuronally-expressed TRP-1 and TRP-2 modulate nicotine-dependent behavior in C. elegans 
(Feng et al., 2006; Xu and Sternberg, 2003).  
C. elegans exhibits a variety of behavioral responses to nicotine, including acute 
response, adaptation, withdrawal and sensitization. Specifically, acute nicotine treatment 
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stimulates locomotion (Feng et al., 2006), an innate behavior that forms the foundation of most, 
if not all behaviors (Piggott et al., 2011). Repeated intermittent administration of nicotine 
sensitizes C. elegans to nicotine, and long-term nicotine treatment elicits tolerance to the drug 
(Feng et al., 2006). Nicotine-adapted worms exhibit hyperlocomotion when placed in a nicotine-
free environment, a withdrawal response to nicotine (Feng et al., 2006). These nicotine 
dependent behaviors require the C. elegans nicotinic acetylcholine receptor (nAChR) genes acr-
15 and acr-16 (Feng et al., 2006). Both genes function in neurons to modulate nicotine responses 
in worms. Notably, trp-1 and trp-2 mutant animals are severely defective in nicotine dependent 
behaviors (Feng et al., 2006). Interestingly, TRP-1 and TRP-2 appear to act downstream of the 
nAChRs ACR-15 and ACR-16 in a PLC-dependent manner (Feng et al., 2006). This work 
further demonstrates that neuronal expression of ACR-15 and ACR-16 as well as TRP-1 and 
TRP-2 are required for nicotine-induced behaviors in C. elegans (Feng et al., 2006). Moreover, 
neuronal Ca2+ influx is greatly diminished in response to nicotine exposure in trp-1 or trp-2 null 
mutant worms, suggesting that these TRPC channels functionally regulate neuronal nicotine 
responses (Benowitz, 2008; Feng et al., 2006). Interestingly, the mouse α4β2 nAChR, which is 
known to be essential for nicotine-associated behaviors, can rescue nicotine behavioral defects in 
acr-15 null mutant animals; similarly, the human TRPC3 channel functionally substitutes for 
worm TRP-2 in nicotine responses (Feng et al., 2006), suggesting that the role of TRPC channels 
and nAChRs in nicotine responses may be evolutionarily conserved.   
In addition to this functional interaction with nAChR, TRPC channels interact with both 
CREB and Homer proteins, which are important for gene transcription related to drug 
dependence and drug-related changes in neural plasticity (Pandey et al., 2005; Ron and Jurd, 
2005; Talavera et al., 2008). Both TRPC3 and TRPC6 overexpression potentiate phosphorylation 
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of CREB which stimulates both early and late CREB-dependent gene transcription (Jia et al., 
2007). The role of this CREB-dependent transcription in drug-induced neural plasticity is well 
documented (Kumar et al., 2011; Philpot et al., 2012). Homer proteins are a group of EVH1 
domain-containing scaffolding proteins involved in coupling metabotropic glutamate receptors 
(mGluR1) and inositol-1,4,5-triphosphate receptors (IP3R) with TRPC channels (Mast et al., 
2010; Yuan et al., 2003). Homer-IP3R interactions regulate trafficking of TRPC3 to the plasma 
membrane, while coupling of mGluR and IP3R with TRPC channels results in mGluR-mediated 
neuronal conductance, which may have a role in drug-related behavioral plasticity (Kim et al., 
2006). Together, these data make a case for more in-depth studies of mammalian TRPC channels 
in relation to drugs of abuse.  
 
Vanilloid TRP (TRPV) channels in drug dependence 
TRPV channels share homology with the founding member of the subfamily, TRPV1, 
which was identified through its response to the vanilloid capsaicin. These channels respond to a 
range of stimuli, such as heat, mechanical stimulation, and pro-inflammatory agents as well as 
other chemical stimuli (Kauer and Gibson, 2009; Venkatachalam and Montell, 2007). 
Mammalian neurons expressing TRPV1 show a decrease in the amplitude of capsaicin-induced 
action potentials after acute nicotine treatment. Moreover, repeated and intermittent nicotine 
treatment sensitizes capsaicin-induced currents in these cells (Liu et al., 2004). Moreover, 
TRPV1 is also known to interact with many nAChRs and is associated with anxiogenic 
behavioral responses, indicating that this channel might be responsible for the anxiety and 
‘nervousness’ associated with nicotine withdrawal responses (Casarotto et al., 2012). Besides, 
the TRPV1 activity is potentiated by ethanol, and Trpv1 null mutants show higher preference to 
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ethanol and higher consumption in two-bottle choice assays as compared to wild-type mice 
(Blednov and Harris, 2009). These findings suggest the role for TRPV1 channels in specific 
behaviors associated to ethanol dependence. 
In invertebrates, the Drosophila TRPV homologue inactive (iav) mediates behavioral 
sensitization to cocaine (McClung and Hirsh, 1998). In this model, stereotypical behavioral 
responses to cocaine include intense grooming at low doses, with moderate doses affecting rapid 
rotations and sideways or backward movements. High doses, in turn, result in tremors and 
paralysis. With repeated cocaine administration, these behaviors become more vigorous in 
response to decreased cocaine concentrations. This behavioral sensitization, however, is not 
present in iav null mutants despite a wild-type response to acute cocaine exposure (McClung and 
Hirsh, 1998). This sensitization deficit appears to result from decreased levels of the 
monoamines tyramine and octopamine, implicating TRPV proteins in the regulation of 
monoamine neurotransmitter systems (McClung and Hirsh, 1999). Thus, both invertebrate 
studies and the findings in rodents suggest TRPV proteins as targets for understanding the action 
that drugs of abuse have on the brain.  
In mammals, the endocannabinoid anandamide (AEA) activates not only the CB1 and 
CB2 GPCRs but also TRPV1. A recent study demonstrates that TRPV1 is critical for long-term 
depression (LTD) of medium spiny neurons (MSN) in the rodent nucleus accumbens and cocaine 
administration disrupts this phenomenon (Grueter et al., 2010). TRPV1 channels are also critical 
for coupling ACh signals with the endocannabinoid 2-archidonylglycerol (2AG) in the striatum. 
This coupling is vital for both LTD and long-term potentiation (LTP) at corticostriatal synapses 
(Musella et al., 2010). Furthermore, the TRPV1 agonist capsaicin induces LTP in the amygdala 
(Zschenderlein et al., 2011). In addition, repeated methamphetamine exposure increases TRPV1 
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mRNA within the prefrontal cortex (Tian et al., 2010), a brain region responsible for inhibiting 
unwanted actions whose dysfunction can lead to hyperactivity and compulsive behaviors such as 
drug-taking (Koob, 2009b).  Collectively, these studies suggest that TRPV1 channels may play a 
role in usurping natural motivational, learning and executive control circuits to effect addiction.    
 
Other TRP channel subfamilies in drug dependence 
Besides TRPC and TRPV subfamilies, other TRPs (mainly TRPA and TRPM) are 
involved either in primary sensing of addictive drugs or in their long-term effects. In vertebrates, 
nicotine activates both TRPM5-dependent and independent gustatory pathways. The TRPM5-
dependent mechanism affects a general taste pathway and is required for nicotine-specific 
behavioral and gustatory cortex circuit responses. It has also been shown to be involved in 
peripheral sensing of nicotine in the nasal cavity (Gulbransen et al., 2008; Oliveira-Maia et al., 
2009).  
TRPA1, meanwhile, is involved in nicotine-induced irritation and facilitates the mouse 
airway constriction reflex to nasal administration of nicotine (Talavera et al., 2008). This channel 
is also known to be responsible for the airway neurological inflammation caused by α,β-
unsaturated aldehydes, one of the main caustic agents in cigarette smoke (Andre et al., 2008). 
These facts make TRPA1 a potential nicotine target for developing smoking cessation 
therapeutics with milder side effects. While TRPA1 acts as an irritant-sensing channel in 
cigarette smoke, the menthol receptor TRPM8 acts as a counterirritant channel in menthol-
flavored cigarettes (Willis et al., 2011). Activation of TRPM8 by menthol suppresses the irritant 
sensation caused by TRPA1 during smoking, thus masking the caustic irritants and promoting 
smoking behavior. These differential actions of TRP channels in the periphery might be 
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important in the preliminary stages of nicotine dependence. In addition, ethanol inhibits TRPM8, 
while potentiating the activity of TRPV1 (Benedikt et al., 2007). Further evidence of the 
complicated role TRP channels play in drug use is seen with ‘hangover pain’, a pathological 
symptom after ethanol consumption, which is mediated by TRPA1 (Bang et al., 2007). 
The effects of addictive drugs on primary targets, such as their cognate receptors, and 
secondary targets, such as kinases and lipases that those receptors modulate, are well known. 
However, the role of those gene families with less obvious involvement in drug addiction, such 
as TRP family channels, remains unclear. Interestingly, there is growing evidence implicating 
TRP channels in drug dependence. TRPC channels, in particular TRPC4/7 were identified in two 
GWA studies. Similarly, two C. elegans TRPC homologues (TRP-1 and TRP-2) are essential for 
nicotine dependent behaviors, and their mammalian counterparts can functionally substitute for 
them, suggesting a functional conservation among species.  
On the other hand, TRPV channels are implicated in the control of extracellular 
monoamine levels, as well as in anxiety-related behaviors, suggesting that these channels might 
be responsible for the neural changes that lead to the adverse effects of withdrawal and 
behavioral sensitization following repeated drug use. This TRP channel subfamily is not only 
involved in behavioral responses to several drugs of abuse, but also performs conserved roles in 
motivational, learning and executive control circuits usurped by drugs of abuse to elicit 
addiction. It is important to note that many more members of the TRP superfamily are implicated 
in responses to drugs of abuse both at the primary sensing level (TRPA1 and TRPM8) and in 
maintaining long-term neural changes (TRPM5). These properties, with the ever-growing 
evidence related to their association with drugs of abuse, support a role for TRP channels in the 
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development of drug dependence, and further investigation is needed to fully understand their 
functional significance in addiction. 
 
C. elegans as a Model for Nicotine-Responsive Behaviors 
 Here, we have touched briefly upon the fundamental psychological processes believed to 
effect addictive behaviors in mammals. We have also given a superficial description of only two 
of the brain regions dysregulated when an individual moves from recreational drug use into 
compulsive, addictive behaviors. While rodent and primate models will always be vital to 
understanding these processes, the complexity of their physiology and their psychology present 
certain challenges. To sidestep these obstacles, we elected to use the soil nematode, C. elegans, 
to evaluate simple models of drug-related behaviors – namely, the stimulation of locomotor 
response to acute nicotine challenge and a native olfactory approach behavior.  C. elegans is an 
hermaphroditic species that is capable of self-fertilization, so has no real motivation to find a 
mate and it obtains water from the medium and bacterial lawn on which it grows (Avery and 
You, 2012; Fitch, 2005; Schafer, 2005), so its motivated behaviors – its psychology, in a manner 
of speaking – is limited to maintaining a readily accessible supply of food and avoiding noxious 
stimuli.  
 The nematode physiology is equally simple (Coghlan, 2005), which is not to say they are 
any less elegant in their evolutionary niche than any other species. C. elegans grows to 
approximately 1 mm in length and has an egg-to-egg generation time of roughly 4 days (Fitch, 
2005), making genetic manipulations much faster than in primates, rodents, or even flies. The 
hermaphrodite nervous system consists of 302 neurons (Hobert, 2010) and the translucent cuticle 
makes the neurons readily accessible for inspection. Furthermore, thanks to sectioning with serial 
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electron microscopy (White et al., 1986), the complete C. elegans connectome is available. 
Moreover, these nematodes respond similarly to many drugs of abuse in a manner commensurate 
with their mammalian counterparts (Feng et al., 2006; Sellings et al., 2013; Sobkowiak et al., 
2011; Ward et al., 2009). For example, in response to nicotine, C. elegans exhibits acute 
locomotor stimulation, shows tolerance and adaptation to prolonged exposure, and demonstrates 
a withdrawal response once the drug is removed (Feng et al., 2006). Furthermore, worms will 
approach a source of nicotine by following the increasing concentration gradient (Sellings et al., 
2013). Accordingly, we delved more deeply into the nematode acute nicotine response, 
identifying an effect of defective insulin signaling mutants and we identified TRPV family 
protein, with no previously characterized phenotype, that plays a crucial role in a nicotine 
olfactory response and chemotaxis. 
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Insulin Family Receptor Signaling in C. elegans 
 
Fig 1.1 illustrates the intracellular signaling cascade following ligand activation of the insulin 
family receptor, DAF-2, in the nematode, C. elegans. Once a peptide hormone binds to the IIS, 
accessory proteins recruit and activate AGE-1/PI3K. In converting PIP2 to PIP3, AGE-1/PI3K 
activates PDK-1, which targets the PKB homologs, AKT-1 and AKT-2. The Akt homologs, in 
turn, phosphorylate DAF-16/FoxO, preventing its translocation to the nucleus. 
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TRP Channel Phylogenetic Tree 
 
Fig 1.2 shows a TRP channel phylogenetic tree with all human TRP channels and representatives 
from other species. Proteins in red are implicated in addiction biology. The letter before the 
protein name indicates the species — c: C. elegans; d: Drosophila melanogaster; h: Homo 
sapiens; m: Mus musculus; z: Danio rerio. 
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Chapter II 
Insulin Signaling Genes Modulate Nicotine-Responsive Behaviors in C. elegans 
 
 Tobacco use is the leading cause of preventable deaths in the developed world, with 
tobacco-related deaths reaching hundreds of thousands annually. Despite this, the one-year 
success rate of tobacco cessation is less than five percent (USPHS, 2008), which means for every 
100 tobacco users who attempt to abstain more than 95 individuals will have relapsed within a 
year of their quit date. A plurality of these addicts will cite weight gain as a major component in 
their relapse and majority of current tobacco users will identify their fear of weight gain as the 
largest impediment to attempting a tobacco cessation program (Shen et al., 2014). Even newly 
abstinent tobacco users who do not increase caloric intake appear to gain weight, particularly as 
body fat, upon tobacco cessation (Bergman et al., 2012) and these abstinent smokers have a 
dramatically increased risk of developing type II diabetes within the first 24 months of nicotine 
abstinence (Bajaj, 2012). Equally disconcerting, however, is that prolonged nicotine use 
increases body fat, particularly intra-abdominal body fat (Bergman et al., 2012), thereby 
increasing waist-to-height ratio, which is the metric that most reliable predicts risk for type II 
diabetes, metabolic syndrome, non-alcoholic fatty liver disease (NFALD), coronary artery 
disease, and cerebrovascular disease (Kahn et al., 2014). 
 As described previously, in C. elegans, the gene daf-2 encodes an ortholog of the 
receptor tyrosine kinases of the insulin receptor (IIS) family. While only a single IIS ortholog 
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exists in C. elegans, daf-2 has splice variants for three distinct isoforms, each with its own 
putative expression pattern and specialized functions (Ohno et al., 2014). Unfortunately, we 
know very little about the DAF-2b and DAF-2c isoforms to date. However, DAF-2c seems to be 
most similar to DAF-2a, appears to be solely expressed in neurons, and is orthologous to the B 
isoform of the mammalian insulin receptor. The DAF-2b isoform, on the other hand, is most 
similar to IGFR but is also enriched in neurons (Murphy and Hu, 2013). In mammals, and likely 
in nematodes, IIS are an α2/β2 heterotetramer with α-subunit ligand-binding domains and β-
subunit kinase domains (Ohno et al., 2014).   
 The insulin signaling pathway plays a crucial role in a host of physiological processes, 
including lifespan and aging (Murphy and Hu, 2013); lipid metabolism and fat regulation 
(Ashrafi, 2007); energy homeostasis and body weight management (Daws et al., 2011); as well 
as a role in learning and memory (Labouebe et al., 2013). However, despite the interaction of 
many, or even most, of these processes with nicotine use in humans, very little work exists 
exploring these connections. Therefore, we present studies here that seek to investigate a link 
between a behavioral response to an acute nicotine challenge and the insulin signaling pathway.  
 
Methods 
 
Acute Nicotine-Induced Locomotion Assay 
 For the acute nicotine locomotion assay, we grew worms on nicotine-free NGM with a 
200 µL lawn of E. coli (OP50) and picked L4 hermaphrodites onto fresh plates 16-20 hours 
before the behavioral test, depending on genetic background. At test, we transferred a single 
worm per plate containing a thinly-spread lawn of 40 µL OP50 and the appropriate nicotine 
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concentration. An automated system tracked the worm as it crawled freely on the plate for 16 
minutes. As described previously (Feng et al., 2006), we discarded the first 11 minutes as the 
worm acclimated to the novel environment and absorbed the nicotine through the cuticle.  We 
then calculated the average crawl speed for the last five minutes of the recording. For the 
wortmannin studies, the plates also contained the appropriate concentrations of the AGE-1/PI3K 
inhibitor. We excluded from analysis any worm that crawled up the side of the plate at any point. 
Each group consists of 20 animals.  
 
Nicotine Locomotor Sensitization Assay 
 For the locomotor sensitization assay, we grew and picked worms as in the acute 
locomotor assay. On the day of test, however, we transferred worms to a clean plate containing a 
lawn of OP50 and either 100 µM nicotine or vehicle for 1 hour before transferring them to a 
second clean, nicotine-free plate for an additional hour. Finally, the worms crawled freely on a 
plate covered in 40 µL OP50 and a 10 µM Nicotine concentration. We then collected and 
analyzed the data as in the acute locomotor assay.  
 
Subjects and Strains Used 
 We maintained the C. elegans strains on nematode growth medium (NGM) [50 mM 
NaCl, 32 g/L BBL Agar, 2.5 g/L peptone, 13 µM cholesterol, 1 mM Ca(CH3COO)2, 1mM 
MgSO4, 25 mM KH2PO4, pH 7.0] seeded with Escherichia coli (OP50) at 20ºC (Avery and 
You, 2012). For any strain not already in our possession, we purchased the line from the 
Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN, USA). For the 
studies presented here, we used the following strains: Bristol N2 (as wild-type), daf-2(e1368), 
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daf-2(e1370), age-1(hx546), pdk-1(sa709), akt-1(mg306), akt-2(ok393), daf-16(mgDF46), daf-
16(mu86), daf-18(e1375), and the double mutant daf-2(e1368);daf-16(mu86). 
 
Results 
 
Wild-Type Nematodes Show Nicotine-Induced Locomotor Stimulation 
 Previously, our lab demonstrated that an acute nicotine challenge induces increased 
locomotion in na ve nematodes. This increased locomotor response depends upon the nAChR, 
ACR-15, and the TRPC homologs, TRP-1 and TRP-2 within the AVA command interneuron 
(Feng et al., 2006). Here, we began by replicating these data. As seen in Fig 2.1, naive, wild-type 
nematodes increase their crawl speed in response to an acute nicotine challenge. This acute 
nicotine response is dose-dependent, with an optimal response to 100 µM nicotine and nicotine-
induced paralysis at 1000 µM nicotine.  
Human drug users often experiment with one or more drugs of abuse but, for many of 
these individuals, drug use will remain recreational without devolving into addiction. However, 
drug-na ve individuals who experience a high initial dose of drug succeeded by a period of 
abstinence are more likely to slide into use of the drug compulsively and to exhibit more 
destructive addiction-related behaviors (Koob and Le Moal, 2005; Robinson, 2004). We, 
therefore, attempted to model this single-dose sensitization in C. elegans. To do so, we pre-
exposed worms to 100 µM nicotine for one hour followed by a one hour period of nicotine 
abstinence. Following this second hour, we then tracked the locomotor response of the worms to 
10 µM nicotine  a concentration that does not stimulate locomotion in na ve animals. Fig 2.2 
shows that animals pre-exposed to a single, high dose of nicotine before the nicotine challenge 
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respond to a 10 µM nicotine dose as though it were the 100 µM nicotine dose. This suggests that 
nematodes, like mammals, are also sensitive to a single-dose regimen for nicotine sensitization.  
 
DAF-2/IIS Hypomorphs Reduce Crawl Speed in Response to Acute Nicotine 
 The insulin signaling pathway affects neural circuits that underlie motivated and 
addiction-related behaviors in mammals, especially the mesolimbic DA system (Daws et al., 
2011). Accordingly, we sought to determine whether strains carrying hypomorphic alleles for the 
nematode IIS homolog, daf-2, had abnormal acute nicotine responses. In Fig 2.3 we see that, 
unlike wild-type animals, when worms carrying alleles hypomorphic for the IIS gene, daf-
2(e1368) or daf-2(e1370), show a dose-dependent decrease in locomotor response, which does 
not differ between the two alleles (data not shown). This is not merely a defective acute nicotine 
response, rather daf-2/IIS mutants show a nicotine phenotype that appears to be a nearly 
complete inversion of the wild-type nicotine phenotype. Moreover, this inverted nicotine 
phenotype sensitizes in daf-2/IIS mutants with previous high (100 µM) concentration nicotine 
exposure (Fig 2.4). As such, not only do DAF-2/IIS mutants show an inverted nicotine 
phenotype, but this behavioral inversion is also susceptible to single-dose sensitization.   
 
AGE-1/PI3K Underperformance Yields Inverted Nicotine Phenotype 
 Upon ligand-binding at DAF-2/IIS, the nematode IRS homolog, IST-1, recruits and 
phosphorylates AGE-1/PI3K, which catalyzes the conversion of PIP2 to PIP3. As the first major 
kinase target of the IIS, we next tested whether a line carrying a hypomorphic allele of age-1 
would decrease crawl speed in response to an acute 100 µM nicotine challenge. Nematodes with 
an under-functioning AGE-1/PI3K show the same inverted nicotine phenotype as the daf-2/IIS 
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mutants (Fig 2.5). As the genetically under-performing AGE-1/PI3K results in nematodes 
crawling slower in response to nicotine, we asked whether we could effect a similar outcome 
pharmacologically. To do so, we grew wild-type worms overnight on the AGE-1/PI3K inhibitor, 
wortmannin, and then tested the response of these worms to 100 µM nicotine. As shown in Fig 
2.6, while wild-type worms exposed to nicotine and a low (10 nM) dose of wortmannin 
responded to nicotine with an increased crawl speed, wild-type animals exposed to nicotine and a 
moderate dose of wortmannin (100 nM) recapitulated the decreased locomotor response seen 
from age-1/PI3K mutants. A high (1000 nM) dose of wortmannin appeared to sicken the worms, 
which resulted in no locomotor changes between worms in the nicotine or control conditions. 
Meanwhile, as an AGE-1/PI3K hypomorph, which converts PIP2 to PIP3, shows a decreased 
crawl speed in response to nicotine, we reasoned that loss of function in the PTEN homolog, 
DAF-18, which works antagonistically to AGE-1/PI3K converting PIP3 back to PIP2, would 
induce an exaggerated nicotine response. That is, it would increase crawl speed in response to 
nicotine above wild-type levels. However, as Fig 2.7 shows, we found instead that daf-18/PTEN 
mutants show a blunted, but not inverted, nicotine phenotype.  Therefore, a nematode with 
underperforming AGE-1/PI3K reduces its crawl speed in response to an acute nicotine challenge 
regardless of whether the source of underperformance derives from a genetic or pharmacologic 
source. However, hyperactivity of AGE-1/PI3K, through loss of the antagonizing phosphatase, 
does not reverse the polarity of this inversion.  
 
 Kinases Downstream of AGE-1/PI3K Yield the Inverted Nicotine Phenotype 
 Once AGE-1/PI3K converts PIP2 to PIP3, PIP3 activates the hypomorphic PDK ortholog, 
PDK-1, As such, we next turned our attention to this kinase and its downstream targets. Fig 2.8 
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shows that PDK-1 hypomorphic animals exhibit the same decreased locomotor response to 
nicotine as daf-2/IIS and age-1/PI3K mutants. It was logical, then, to investigate targets of PDK, 
which include Akt/PKB. The C. elegans genome encodes two Akt homologs involved in the IIS 
signaling pathway, akt-1 and akt-2. Loss of function in either akt-1 or in akt-2 also shows the 
decreased locomotor phenotype in response to an acute nicotine challenge (Fig 2.9). Therefore, 
the kinases downstream of AGE-1/PI3K, pdk-1, akt-1, and akt-2 all show the same inverted 
behavioral phenotype in response to acute nicotine challenge as daf-2/IIS.  
 
DAF-16/FoxO Nuclear Activity is Critical for a Normal Nicotine Phenotype 
 The ultimate target of the IIS signaling pathway is the FoxO family of transcription 
factors. In C. elegans, daf-16 encodes the sole FoxO transcription factor. In lifespan and dauer 
formation assays, daf-16/FoxO mutations rescue the phenotypes of daf-2/IIS mutants (Murphy 
and Hu, 2013). We, therefore, expected worms carrying one of the loss of function daf-16/FoxO 
mutations to show the reduced crawl speed in response to acute nicotine challenge. However, 
while strains carrying either of the null alleles, daf-16(mu86) or daf-16(mgDF46), showed 
defects in their acute nicotine response (Fig 2.10), these daf-16/FoxO mutants did not show the 
decreased locomotor response observed from DAF-2/IIS mutants. As these two alleles did not 
differ from one another, we present them here collectively.  With the disparity in the daf-2/IIS 
and daf-16/FoxO phenotypes, we next tested whether these two genes are, in fact, functioning in 
the same pathway to mediate an acute nicotine response. If the daf-2/IIS and daf-16/FoxO genes 
act in the same pathway in this nicotine-responsive behavior, we expect the daf-2;daf-16 double 
mutant should perform similarly to the daf-16/FoxO mutant alone. If, however, the two genes are 
functioning in distinct pathways for this nicotine-responsive behavior, we expect a double 
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mutant phenotype that is intermediate to the individual single mutants. As Fig 2.11 demonstrates, 
daf-2;daf-16 double mutants show the same nicotine defect we see with the daf-16/FoxO 
mutants suggesting these two genes, daf-2/IIS and daf-16/FoxO, are functioning in the same 
pathway here, as well. Therefore, while daf-16/FoxO is downstream of daf-2/IIS in the signaling 
pathway mediating the acute response to nicotine challenge, daf-16/FoxO shows a defective, but 
not inverted, phenotype in this nicotine responsive-behavior.  
 
Discussion 
 
 In C. elegans, the insulin receptor and the insulin-like growth factor have not yet 
diverged, and the product of the daf-2/IIS gene functions as a single receptor tyrosine kinase that 
is responsive to the approximately 40 insulins encoded in the genome of these animals (Murphy 
and Hu, 2013). In mammals, all of the known insulin family tyrosine receptor kinases activate 
the PI3K/PDK/Akt kinase cascade (Sugano et al., 2006), which is the major kinase target of 
DAF-2, as well (Murphy and Hu, 2013). Interestingly, there is evidence to suggest that nAChR 
activation of this same kinase cascade might mediate the neuroprotective effects of nicotine in 
aging neurons (Davis et al., 2010; Daws et al., 2011). Moreover, we know that weight-gain is the 
reason cited most often for relapse following tobacco cessation (Bergman et al., 2012), which 
implicates an interaction between cholinergic signaling pathways and the IIS signaling pathways.  
 The studies presented here replicate the wild-type locomotor stimulation in response to 
nicotine our lab has described previously (Feng et al., 2006). We show that wild-type C. elegans 
dose-dependently increases crawl speed in response to an acute nicotine challenge, with the 
highest doses of nicotine having a paralytic effect on the worms. Additionally, while we have yet 
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to explore it in greater detail, we show here that this acute locomotor nicotine phenotype is prone 
to single-dose sensitization. This brief, high-dose exposure to nicotine, preceding an abstinent 
period before a low-dose challenge is commensurate with human addiction-prone, drug-taking 
behaviors. That is, individuals who cycle through periods of drug binge and abstinence may be 
more likely to devolve into destructive addiction-related behaviors than lighter, if more 
consistent, recreational users (Koob and Le Moal, 2005; Robinson, 2004).   
 When we turned our attention to worms carrying reduction-of-function alleles for the IIS 
ortholog gene, daf-2, we found that nicotine-naive nematodes yield an inverted phenotype when 
acutely challenged with nicotine. Rather than increasing their crawl speed as wild-type worms 
do, or simply ignoring the nicotine as acr-15/α7nAChR null mutants do, the daf-2/IIS 
hypomorphic mutants crawl slower when acutely challenged with nicotine. In these worms, 
nicotine appears to act as a depressant rather than as a stimulant. This effect is not present at low 
doses of nicotine and becomes more apparent with increasing nicotine concentration. However, 
the worms do not become paralyzed, despite this decreased locomotor speed. In fact, both wild-
type and daf-2/IIS worms first show nicotine-induced paralysis at the same concentration (1000 
µM). Moreover, this effect sensitizes just as the wild-type nicotine response does. When naive 
daf-2/IIS worms experience a high dose of nicotine followed by a brief period of abstinence, they 
respond robustly to a low dose of nicotine that elicits no response in naive animals. This nicotine 
response is, again, a decrease in crawl speed when challenged with the low nicotine dose.  
 This inverted nicotine phenotype persists throughout the kinase cascade downstream of 
the IIS, as well. Worms hypomorphic for the PI3K homolog, age-1, respond to nicotine with a 
slowed crawl speed and this genetic effect is dose-dependently recapitulated when wild-type 
worms experience nicotine in the presence of the AGE-1/PI3K inhibitor, wortmannin. As such, 
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both genetic and pharmacologic manipulations seem to corroborate this unique effect of an 
insulin signaling pathway that is under-performing when exposed to nicotine. Moreover, loss of 
function in the PDK ortholog, pdk-1, or in either of the Akt2 homologs, akt-1 or akt-2, show a 
similar response to nicotine. For ease of inspection, Fig 2.12 collates all of these genotypes. 
 The C. elegans genome encodes a single FoxO transcription factor, daf-16. This FoxO 
transcription is necessary for extending life-span via decreased IIS signaling in nematodes 
(Murphy and Hu, 2013) and is crucial in a number of other phenomena that require IIS activity 
as well. Accordingly, we tested two separate null alleles for daf-16/FoxO in this acute nicotine 
paradigm. In both cases, daf-16/FoxO mutants showed no decreased crawl speed in response to 
nicotine. However, strains carrying either of the null alleles were also defective in the wild-type 
nicotine response. As daf-2/IIS and daf-16/FoxO mutants differed phenotypically from one 
another, we next sought to determine whether these two genes act in the same pathway or in 
separate pathways in response to an acute nicotine challenge. To probe this, we used a daf-2;daf-
16 double mutant. If the two genes are acting in the same pathway, the double mutant should 
phenocopy the downstream gene, in this case daf-16/FoxO. If, however, the two genes are acting 
in separate pathways, the double mutant should show some form of an intermediate phenotype. 
As it happens, the double mutants phenocopy daf-16/FoxO mutants, which suggests that daf-
16/FoxO is acting downstream of daf-2/IIS here as well. It is likely that the divergent phenotypes 
seen between these two genotypes is due to a secondary loss of activity from one of the gene 
products the FoxO transcription regulates.  
 As all of the kinases known to be between daf-2/IIS and daf-16/FoxO resulted in a 
decreased crawl speed, we hypothesized that a loss-of-function mutation in the PTEN homolog, 
daf-18, would yield an exaggerated increase in crawl speed to levels greater than those seen with 
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wild-type worms in response to nicotine. Alas, this was not the case. Rather, we found that daf-
18/PTEN mutants neither increased nor decreased their crawl speed in response to nicotine, 
which phenocopies the acr-15/α7nAChR mutants (Feng et al., 2006) and our daf-16/FoxO 
findings. 
 It would seem that the most likely explanation of these findings involves a precarious 
balance of kinase and phosphatase activity within the cell to elicit a normal acute nicotine 
phenotype. Under normal conditions, the phosphorylation of DAF-16/FoxO is tightly regulated. 
In its unphosphorylated state, DAF-16/FoxO is free to translocate to the nucleus and induce gene 
transcription. Phosphorylation, however, locks DAF-16/FoxO into the cytosol. Accordingly, a 
loss of DAF-16/FoxO activity, either through null mutation in the daf-16/FoxO gene or increased 
phosphorylation due to decreased DAF-18/PTEN activity results in an inability to respond to 
acute nicotine as one or more FoxO-regulated genes are not transcribed or are transcribed 
ineffectively. Meanwhile, when the IIS or any of its kinases are under-performing, DAF-
16/FoxO is less likely to be phosphorylated and becomes overly permissive in gene transcription, 
and some constellation of its gene targets interact to produce the decreased crawl speed in 
response to an acute nicotine challenge. This is summarized in Fig 2.13.  
 It is unlikely that nicotine is acting directly at the IIS. Rather, we expect that nicotine is 
acting first at a nAChR (probably ACR-15) and is inducing the release of one or more insulins. 
These ligands then are likely acting at the IIS on some target cell capable of regulating crawl 
speed. In fact, our lab recently identified a neuron that may serve to control speed generally (Li 
et al., 2014), and it is an attractive candidate to examine in this nicotine paradigm. With roughly 
40 insulins working redundantly with each other (Murphy and Hu, 2013), however, it seems 
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improbable to identify a single insulin whose loss would be sufficient to cause the inverted 
nicotine phenotype of daf-2/IIS mutants.  ! !
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Locomotor Response of Wild-Type Nematodes to Acute Nicotine Challenge 
 
Fig 2.1 shows the locomotor response of nicotine-naive nematodes at a range of concentrations. 
When compared to the nicotine-free (‘0 µM’) group [Mean: 69.1 µm/s ±6.88], the ‘100 µM’
group [Mean: 125.5 µm/s ±10.69] crawls significantly faster, while the ‘1000 µM’group [Mean: 
13.9 µm/s ± 0.78] crawls significantly slower, most likely due to nicotine-induced paralysis at 
this concentration. The ’10 µM’group [Mean: 81.5 µm/s ± 10.29] is not significantly different 
from control animals [one-way ANOVA p < 0.0001; post hoc Dunnett’s MCT]. 
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Single-Dose Sensitization of Wild-Type Acute Nicotine Locomotor Response 
 
Fig 2.2 shows the locomotor response of wild-type nematodes in an acute or sensitizing nicotine 
paradigm. Animals in both the ‘Acute’group [Mean: 39.5µm/s ± 3.37] and ‘Sensitized’group 
[Mean: 74.6 µm/s ± 1.62] received a 10 µM nicotine challenge. However, ‘Sensitized’received a 
one hour pretreatment with 100µM nicotine followed by an hour of nicotine withdrawal before 
the 10 µM nicotine challenge. ‘Acute’animals experienced fresh, nicotine-free plates for each of 
these transfers. When compared to the ‘Naive’ group [Mean: 44.5 µm/s ± 2.87] that never 
experienced nicotine, the ‘Sensitized’animals crawled significantly faster in response to a 10 µM 
nicotine challenge, while ‘Acute’worms behaved no differently than the ‘Naive’controls [one-
way ANOVA p < 0.0001; post hoc Dunnett’s MCT].   
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Locomotor Response of daf-2/IIS Mutants to Acute Nicotine Challenge 
 
Fig 2.3 shows the locomotor response of nematode strains carrying alleles hypomorphic for the 
IIS ortholog, DAF-2. As the two strains tested, daf-2(e1368) and daf-2(e1370), were not 
different from one another, their data are presented here collectively. Neither the ‘10 µM’[Mean: 
33.3 µm/s ± 4.73] nor the ’50 µM’[Mean: 25.2 µm/s ± 1.85] groups were significantly different 
from the ‘0 µM’ [Mean: 35.4 µm/s ± 4.58] group, although the ‘50 µM’ did show a trend 
towards significance. The ‘100 µM’ [Mean: 17.7 µm/s ±2.11], ’500 µM’ [Mean: 16.8 µm/s 
±2.56], and ’1000 µM’ [Mean: 9.1 µm/s ± 0.63] groups were all crawled significantly slower 
than the nicotine-free control group when faced with an acute nicotine challenge [one-way 
ANOVA p < 0.0001; post hoc Dunnett’s MCT]. Animals in the ’1000 µM’ showed signs of 
nicotine-induced paralysis comparable to what was seen with wild-type animals, while the 100 
µM and 500 µM worms show normal, non-paralytic body curvature.   
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Single-Dose Sensitization of daf-2/IIS Acute Nicotine Locomotor Response 
 
Fig 2.4 shows that the decreased crawl speed of daf-2 mutants is subject to single-dose 
sensitization in a manner commensurate with wild-type animals. Again, animals in both the ‘10 
µM’group [Mean: 31.5 µm/s ± 6.21] and ‘Sensitized’group [Mean: 20.1 µm/s ±1.77] received a 
10 µM nicotine challenge. However, ‘Sensitized’received a one hour pretreatment with 100 µM 
nicotine followed by an hour of nicotine withdrawal before the 10 µM nicotine challenge. ‘0 µM’ 
and ‘100 µM’ [Mean: 18.2 µm/s ± 2.65] animals experienced fresh, nicotine-free plates for each 
of these transfers. When compared to the ‘0 µM’group [Mean: 38.8 µm/s ±5.57] or the 10 µM 
group [Mean: 31.5 µm/s ± 6.21], the ‘Sensitized’ animals crawled significantly slower in 
response to a 10 µM nicotine challenge and were no different from naive animals receiving a 100 
µM, while ‘10 µM’worms behaved no differently than the ‘0 µM’controls [one-way ANOVA p 
< 0.01; Dunnett’s MCT].  
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Locomotor Response of age-1/PI3K Mutants to Acute Nicotine Challenge 
 
Fig 2.5 shows the locomotor response of age-1/PI3K mutants in response to an acute 100 µM 
dose of nicotine. age-1/PI3K mutants crawl slower in response to a 100 µM nicotine challenge 
[Mean: 49.3 µm/s ± 4.70] than do nicotine-naive age-1/PI3K mutants [Mean: 88.6 µm/s ± 8.03] 
[one-tailed t-Test, p < 0.0001].   
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Effects of age-1/PI3K Inhibitor Wortmannin on Acute Nicotine Response 
Fig 2.6 shows the effects of Wortmannin, a 
PI3K inhibitor on the locomotor response of 
wild-type nematodes challenged with a 100 
µM dose of nicotine. Fig 2.6a shows that 10 
nM Wortmannin has no effect on the wild-
type acute nicotine response as worms 
receiving both nicotine and wortmannin 
[Mean: 117.7 µm/s ± 1.84] have an increased 
crawl speed than worms receiving 
wortmannin alone [Mean: 66.3 µm/s ± 3.38] 
[one-tailed t-Test, p < 0.01]. Fig 2.6b shows 
wild-type worms experiencing a 100 µM 
nicotine challenge in the presence of 100 nM 
Wortmannin [Mean: 24.1 µm/s ± 1.10] have a 
decreased crawl speed when compared to the 
Wortmannin alone group [Mean: 67.5 µm/s ± 
3.03] [one-tailed t-Test, p < 0.01]. This 
phenocopies worm strains hypomorphic for AGE-1/PI3K. Fig 2.6c demonstrates the high, 1000 
nM dose of Wortmannin sickens the animals resulting in minimal movement whether nicotine is 
present [Mean: 12.07 µm/s ± 1.00] or absent [Mean: 12.7 µm/s ± 0.81] [one-tailed t-Test, p = 
0.2842].   
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Locomotor Response of daf-18/PTEN Mutants to Acute Nicotine Challenge 
 
Fig 2.7 shows the locomotor response of daf-18/PTEN mutants in response to an acute 100 µM 
nicotine challenge. daf-18/PTEN mutants crawl at the same speed whether nicotine is present 
[Mean: 56.0 µm/s ± 6.98] or absent [Mean: 60.3 µm/s ± 6.05] [one-tailed t-Test, p = 0.3199].   
0 uM 100 uM
0
20
40
60
80
100
Fig 2.7
Nicotine Concentration
Sp
ee
d 
(u
m
/s
)
! 46!
Locomotor Response of pdk-1 Mutants to Acute Nicotine Challenge  
 
Fig 2.8 shows the change in locomotor output of  pdk-1 mutants in response to an acute nicotine 
challenge. pdk-1 mutants crawl at slower speed in response to a 100 µM nicotine challenge 
[Mean: 33.3 µm/s ± 2.40] than do pdk-1 mutants not exposed to nicotine [Mean: 68.6 µm/s ± 
3.88] [one-tailed t-Test, p < 0.0001].   
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Locomotor Response of AKT Mutants to Acute Nicotine Challenge 
 Fig 2.9 shows the change in 
crawl speed of the two C. 
elegans Akt/PKB homologs 
in response to an acute 100 
µM nicotine challenge. Fig 
2.9a demonstrates the 
decrease in locomotion of 
akt-1 mutants in response to 
a 100 µM challenge [Mean: 
42.0 µm/s ± 5.04] when 
compared to nicotine-naive 
mutants [Mean: 76.3 µm/s ± 
5.35] [one-tailed t-Test, p < 
0.0001]. Fig 2.9b shows akt-
2 mutants exposed to 100 
µM nicotine [Mean: 38.6 
µm/s ± 4.58] crawl slower than their nicotine-naive controls [Mean: 55.2 µm/s ± 4.99] [one-
tailed t-Test, p < 0.01]. 
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Locomotor Response of daf-16/FoxO Mutants to Acute Nicotine Challenge 
 
Fig 2.10 shows the locomotor response of daf-16/FoxO mutants. As the two strains tested, daf-
16(mgDF46) and daf-16(mu86), were not different from one another, their data are presented 
here collectively. daf-16/FoxO mutants exposed to 100 µM nicotine [Mean: 62.1 µm/s ± 7.55] do 
not crawl at a different speed than nicotine-naive daf-16/FoxO mutants [Mean: 68.1 µm/s ± 6.13] 
[one-tailed t-Test, p = 0.2657].  
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Locomotor Response of daf-2:daf-16 Mutants to Acute Nicotine Challenge 
 
Fig 2.11 shows the locomotor response of daf-2;daf-16 double mutants in response to an acute 
100 µM nicotine challenge. Double mutants exposed to 100 µM nicotine [Mean: 48.9 µm/s ± 
5.07] crawl at a speed that is not significantly different from double mutants exposed to no 
nicotine [Mean: 46.2 µm/s ± 4.74] [one-tailed t-Test, p < 0.3418]. As the double mutant 
phenocopies the daf-16/FoxO single mutant instead of presenting a phenotype intermediate to the 
daf-2/IIS and daf-16/FoxO single mutants, it is likely that these two genes are working in the 
same pathway in response to nicotine and daf-16/FoxO is downstream of daf-2/IIS.  
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Comparison of Insulin Signaling Mutants in Acute Nicotine Response 
 
Fig 2.12 shows the percent change in response of insulin signaling mutants to an acute challenge 
of 100 µM nicotine relative to their controls on nicotine-free plates. The DAF-2/IIS mutants and 
the mutants for each of the downstream kinases —AGE-1/PI3K, PDK-1, AKT-1, and AKT-2 —
show the inverted nicotine phenotype, the depressant response to nicotine. Loss of either DAF-
18/PTEN or DAF-16/FoxO, however, results in a blunted, defective nicotine phenotype.    
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Model of Insulin Signaling Mutants Response to Acute Nicotine Challenge 
!
Fig!2.13!illustrates!a!model!that!may!explain!the!role!of!insulin!signaling!in!these!aberrant!nicotine! responses.! A! normal,! stimulating! nicotine! response! depends! upon! a! proper!balance!between!the!cytosolic!and!nuclear!activity!of!DAFG16/FoxO.!In!its!phosphorylated!state,!DAFG16/FoxO!is!sequestered!in!the!cytosol!while!the!unphosphorylated!state!allows!DAFG16/FoxO!to!translocate!to!the!nucleus.!When!the!transcription!factor!is!in!physiologic!balance!between!these!two!states,!nicotine!induces!a!stimulatory!response.!However,!when!DAFG16/FoxO! is! overly! phosphorylated,! as! in! the! case! of! the! daf$18/PTEN! mutants,! or!missing,!as!in!the!case!of!the!daf$16/FoxO!mutants,!the!loss!of!nuclear!activity!results!in!the!blunted!response!and!defective!nicotine!phenotype.!In!contrast,!reduced!phosphorylation,!as!in!the!case!of!the!daf$2/IIS!and!downstream!kinase!mutants!is!overly!permissive!of!DAFG16/FoxO! activity! in! the! nucleus,! which! results! in! the! inverted,! depressant! response!phenotype!when!the!animal!experiences!nicotine!challenge.!
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Chapter III 
TRPV Channels Regulate Nicotine Chemotaxis in the Nematode, C. elegans 
 
 As explained previously, drug addiction is a psychiatric disease state in which the 
rewarding effects of a drug of abuse come to usurp adaptive neural mechanisms mediating 
motivated behaviors, resulting in the compulsive and impulsive self-administration of a chemical 
substance, despite negative consequences for these actions (Koob and Le Moal, 2005; Robinson, 
2004; Robinson and Berridge, 1993). While direct cognate receptors for most drugs of abuse are 
known, we have only just begun to plumb the complicated depths of the synaptic plasticity drugs 
of abuse induce in neurons (Kauer, 2004; Kauer and Malenka, 2007). In fact, an increasing body 
of literature suggests transient receptor potential (TRP) channels may be important secondary 
targets for drugs of abuse in mammalian and invertebrate models of addiction-related behaviors 
(Wescott et al., 2013).  
 In order to survive, an organism must be able to monitor its environment. C. elegans 
employs a number of sensory systems - osmosensation, chemosensation, mechanosensation - to 
achieve this end. Pertinent to the discussion at hand, chemosensation can be further divided into 
gustation —the ability to “taste”or detect salts and water-soluble molecules —and olfaction —
the ability to “smell”or detect volatile, airborne chemicals (Bargmann, 2006). Typically, these 
nematodes can detect volatile chemicals at much lower concentrations than they detect water-
soluble chemicals. Generally, nematode olfaction detects in nano- to  low micormolar range 
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while gustation is more often in the micro- to  low millimolar range (Bargmann, 2006). The 
ciliated chemosensory neurons necessary for olfaction and gustation are enclosed in the amphid, 
which is a nematode-specific sensory structure comprised of a series of invaginations near the 
pharynx at the anterior end of the worm. Within the amphid, there are three distinct pairs of 
neurons known to mediate olfaction (Bargmann, 2006). The AWA and AWC neurons are 
responsible for detecting appetitive or attractive odorants (Bargmann et al., 1993), while the 
AWB neurons respond to non-noxious, aversive or repulsive odorants (Troemel et al., 1997). A 
separate, polymodal neuron pair, the ASH neurons, are thought to be responsible for detecting 
most noxious stimuli regardless of sensory modality (Tobin et al., 2002). 
 Among the appetitive odorants to which C. elegans chemotaxes benzaldehyde, butanone, 
isoamyl alcohol, and 2,3-pentanedione all activate the AWC neurons, while AWA detects 
diacetyl and pyrazine. Both neuron classes are capable of detecting 2,4,5-trimethylthiazole, 
however (Bargmann, 2006; Bargmann et al., 1993). Curiously, the AWC neurons demonstrate a 
random lateralization across individual animals such that one AWC neuron detects benzaldehyde 
and the other detects butanone but neither neurons detects both these chemicals, but with no 
predictable sequence to whether the right or left AWC will be receptive to benzaldehyde 
(Troemel et al., 1999). To date, no studies have identified this sort of lateralization in the AWA 
neurons. In turning attention to drugs of abuse, evidence exists demonstrating that nematodes can 
chemotax up a nicotine concentration gradient (Sellings et al., 2013) but the study in question 
was unable to identify a chemosensory neuron responsible for detecting nicotine.  
 As one might expect, in addition to neurons, a number of genes are imperative for 
appropriate chemosensory behaviors in C. elegans. Prime among the genes known to have a role 
in nematode chemosensation are several G proteins, especially Gi-like genes, including odr-3 
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(ODorant Response abnormal), gpa-2 (G Protein Alpha subunit), gpa-3, gpa-5, gpa-6, and gpa-
13 (Bargmann, 2006). The ODR-3 G protein, which is localized to sensory cilia, is necessary for 
full chemosensory responses to every odorant characterized to date (Jansen et al., 1999; Roayaie 
et al., 1998).  
 In AWA, for example, ODR-3 serves a G protein downstream of the diacetyl-sensitive 
GPCR encoded by odr-10 (Roayaie et al., 1998). Diacetyl acts as a ligand at ODR-10 receptors. 
This increases ODR-3 activity, which eventually leads to signal transduction through a 
heteromeric ion channel encoded by the TRPV genes osm-9 (OSMotic avoidance abnormal) and 
ocr-2 (Osm-9 and Capsaicin receptor-Related) (Colbert, 1997; Tobin et al., 2002). A similar 
process appears to be at work for all known olfactory stimuli as well as for most other 
chemosensory and noxious stimuli (Bargmann, 2006). In fact, in the nociceptive ASH neuron, 
ODR-3 and the OSM-9/OCR-2 complex appear to have clear roles in response to noxious stimuli 
(Kahn-Kirby et al., 2004). Interestingly, not only are both OSM-9 and OCR-2 proteins localized 
to the sensory cilia in both AWA and ASH, but they each appear to be necessary for the 
appropriate trafficking of the other. Mutants lacking either ocr-2 or osm-9 are defective in 
olfactory chemotactic responses for every volatile chemical tested in C. elegans (Colbert and 
Bargmann, 1995), while, at present, no one has identified a clear behavioral phenotype for 
nematodes lacking a functional copy of ocr-1, another TRPV gene expressed in the AWA and 
ADL neurons.   
 Oddly, there are precious few studies to examine nicotine responses in freely behaving 
nematodes and most of the studies that exist are relatively recent and none have investigated a 
role for TRPV Channels in these behaviors. As noted previously, work from our lab shows that 
C. elegans exhibits a number of behavioral response when exposed acutely to nicotine (Feng et 
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al., 2006). Nicotine-exposed worms increase their crawl-speed acutely; they adapt to prolonged 
nicotine treatment; they show withdrawal behaviors when removed from a nicotine-rich 
environment; and, they show sensitization to repeated nicotine administration. These early 
studies provided evidence of a clear role for the AVA command interneuron, and its nAChR and 
TRPC Channels in these behaviors (Feng et al., 2006). For the behavioral paradigm in question, 
worms crawled freely on plates with a uniform nicotine concentration and it was assumed the 
nicotine effects were due to the diffusion of the drug through the cuticle until it reached its 
cognate receptor on the command interneuron.  
 More recently, a group consisting of Sellings, Pereira and their colleagues probed 
whether C. elegans nicotine chemotaxis as a nematode model of motivated behaviors (Sellings et 
al., 2013). Their studies showed worms will chemotax up a nicotine concentration gradient of the 
drug allowed to diffuse through the medium and worms will show a place preference for a non-
paralyzing concentration of nicotine (50 µM) versus vehicle as well as conditioning a preference 
for butanone [a normally repellant odorant (Bargmann, 2006)] after it was paired with nicotine. 
The Sellings-Pereira group also identified both two nACh receptors (ACR-5, ACR-15) and two 
DOPamine receptors (DOP-1, DOP-2) as critical for nematode nicotine approach behavior in this 
paradigm (Sellings et al., 2013). Sellings and Pereira posit a complicated model to explain this 
nicotine approach behavior in which nicotine diffuses through the cuticle to act as ligand at 
ACR-15 receptors expressed on the AVA command interneuron. Through gap junctions, this 
AVA depolarization activates the mechanosensory neural circuits that feed back onto a second 
command interneuron, AVB, which then releases ACh onto the B-type, cholinergic motor 
neurons, which express ACR-5 receptors. This pathway, they suggest, then induces locomotion 
towards the point-source of nicotine (Sellings et al., 2013).  
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Methods 
 
Chemotaxis Assays 
 For chemotaxis assays, we used standard 10 cm Petri dishes containing 15 mL of an 
optimized nematode chemotaxis medium [1.6% BBL agar; 1 mM MgSO4; 1 mM CaCl; 5 mM 
KPO4]. We poured chemotaxis plates fresh within the week of testing, allowed the plates to settle 
overnight on the bench, before storing them at 4ºC until used. On test day, we allowed the plates 
to warm on the bench to 20ºC, before partitioning the outside of the dish with felt-tip pen into 
three sections - an “attractant”(A), a “control”(R), and a “middle”(M) section. We then set the 
plates with the lids removed on the bench for an additional hour to allow for the evaporation of 
any excess moisture remaining from the time stored in the cooler. At the end of this hour, we 
washed each strain of worms from the plate on which it was grown into a 1.5 mL 
microcentrifuge tube with 1.5 mL S Basal [100 mM NaCl; 6 mM K2HPO4; 44 mM KH2PO4; 13 
µM Cholesterol in H20] and allowed them to settle for 3 min before drawing off the supernatant 
and rinsing them twice more with S Basal before a final rinse with ddH20. We then transferred a 
population of 50-150 L4 and early Day 1 worms to the “start box”on each chemotaxis plate, 
adding the attractant (nicotine or diacetyl diluted in ethanol) and the control (ethanol diluent 
alone). We then placed the dishes upside down and allowed the to sit undisturbed for one hour. 
At the end of the hour, we calculated a chemotaxis index (CI) by counting the number of worms 
within the “A”partition less the worms in the “C”partition and dividing that number by the total 
number of worms to leave the “start box”: (A-C) ÷(A+C+M) = CI. This yielded a CI between 
+1.00 (absolute attraction) and -1.00 (absolute repulsion) with a score of 0.00 being chance. Fig 
3.1 illustrates this. We replicated each chemotaxis assay in triplicate. 
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Subjects and Strains Used 
 We maintained the C. elegans strains on nematode growth medium (NGM) [50 mM 
NaCl, 32 g/L BBL Agar, 2.5 g/L peptone, 13 µM cholesterol, 1 mM Ca(CH3COO)2, 1mM 
MgSO4, 25 mM KH2PO4, pH 7.0] seeded with Escherichia coli (OP50) at 20ºC. For any strain 
not already in our possession, we purchased the line from the Caenorhabditis Genetics Center 
(University of Minnesota, Minneapolis, MN, USA). For the studies presented here, we used the 
following strains: Bristol N2 (as wild-type), acr-2(ok1887), acr-5(ok180), acr-8(ok340), acr-
9(ok933), acr-11(ok1345), acr-12(ok367), acr-14(ok455), acr-15(ok1214), acr-16(ok789), acr-
18(ok1285), acr-19(ok967), deg-3(u701), eat-2(ad465), lev-8(x15), lgc-40(n4545), ocr-1(ak46), 
ocr-1(ok132), ocr-2(ak47), ocr-3(ok1559), ocr-4(vs137), odr-3(n2150), odr-10(ky32), osm-
9(ky10), trpa-1(ok999), the double mutant ocr-1(ok132);ocr-2(ak47), the quadruple mutant ocr-
1(ok132);ocr-2(ak47);osm-9(ky32);trpa-1(ok999), and the rescue line: ocr-1(ok132);xuEx[Podr-
10::OCR1::SL2::mCherry].  
 
Results 
 
Worms Can Chemotax to a Point-Source of Nicotine 
 As previously discussed, we decided to investigate whether C. elegans is capable of 
crawling to a point-source of nicotine that is not diffusing through the NGM or through the 
cuticle of the animal. To this end, we tested a range of nicotine dilutions (in ethanol) by placing a 
2 µL drop of the nicotine:ethanol mixture on the lid of the plate while the worms crawled on the 
surface of the NGM. To prevent the nicotine from dripping onto the medium, the plates sat 
upside-down during the test. This paradigm has proven reliable in diacetyl olfactory chemotaxis 
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assays (Bargmann et al., 1993) and, as such, we used diacetyl diluted in ethanol (1:1000) as a 
positive control (Fig 3.2a). As Fig 3.2b shows, worms chemotax reliably to nicotine (1:50) when 
compared to ethanol alone [two-tailed t-Test, p < 0.0001], although their chemotaxis to diacetyl 
(1:1000) is significantly greater than the nicotine chemotaxis (Fig 3.2c). While we did not 
explore it further here, the difference in chemotaxis index between nicotine and diacetyl is likely 
due to the ability of nematodes, like mammals, to select among various stimuli in their 
environment. To do so, different appetitive stimuli should have different motivational salience or 
weighting.  
While worms reliably chemotax to a 1:50 dilution of nicotine, we next explored their 
chemotaxis to a range of nicotine dilutions. As seen in Fig 3.3, wild-type worms are able to 
chemotax to a host of nicotine dilutions successfully when compared to the No Nicotine control. 
Worms responded with robust chemotaxis to the 1:100, 1:50, 1:25, 1:5, and Pure Nicotine 
dilutions, with animals in each of these conditions significantly better than those in the No 
Nicotine condition at finding the “attractant” spot. As the 1:50 dilution seemed to be elicit a 
particularly optimal response in wild-type worms, we selected this 1:50 nicotine dilution for the 
candidate screens to follow. In the 1:500 condition, worms performed no better than animals in 
the No Nicotine group. 
 Generally, especially with drugs of abuse, there is some lower threshold at which 
the drug is ineffective in eliciting a response as well as an upper threshold at which the amount 
of drug present has catastrophic effects on the ability of the animal to perform.  We expected to 
see this typical inverted U	 for a dose-response curve across the various dilutions in this assay. 
What we see, however, is less of an analog, dose-response curve and much more a digital, 
responsive-unresponsive threshold. There is a dilution below which worms begin to respond in 
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this olfactory assay, but once the threshold is reached worms respond similarly to most dilutions 
above that point. This is reminiscent of the digital cliff in the telecommunications industry 
where a digital signal is perceived to have perfect reception or not to exist at the receiving end 
where as analog signals gradually decrease in strength and clarity until they are too degraded for 
reception. Additionally, this could be compared to the all-or-nothing nature of action potential  
once threshold is reached, the depolarization of the neuron results in an action potential firing 
down the axon whether more depolarization is present or not but sub-threshold excitations do 
not. Regardless of the imagery we choose to describe it, wild-type nematodes are capable of 
chemotaxing to a source of nicotine. 
 
Acetylcholine Receptors Have No Apparent Role in Nicotine Chemotaxis 
 Nicotine is an exogenous ligand at nAChR, a family of receptors for which the C. elegans 
genome encodes at least 27 genes with approximately 20 of these encoding putative α-subunits. 
As these proteins were the most likely candidate to serve as nicotine receptor, we next screened 
all of the available nAChR α-subunit mutants without any noticeable phenotypically abnormal 
locomotor behaviors. Despite our expectations to the contrary, none of the strains carrying null 
mutations in a nAChR α-subunit we tested were defective in their ability to locate a point-source 
of nicotine (Fig 3.4). This suggests that something else must act as the nicotine chemoreceptor.  
 
TRPV Genes Regulate Nicotine Chemotaxis 
 Previous work from our lab demonstrates a role for TRP channels in an acute nicotine 
response (Feng et al., 2006) and TRPV channels play a significant role in nematode sensory 
behaviors (Bargmann et al., 1993; Colbert and Bargmann, 1995; Colbert, 1997; Tobin et al., 
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2002; Troemel et al., 1997; Troemel et al., 1999). Meanwhile, nAChR appear to have no role in 
our paradigm for chemotaxis to nicotine. Accordingly, we next screened worm lines with null 
mutations in TRPV homologs (Fig 3.5). Despite the fact that ocr-1 has never shown a significant 
role in chemosensation previously, two separate null alleles for ocr-1 show deficits in nicotine 
chemotaxis. Moreover,  the quadruple mutant ocr-1;ocr-2;osm-9;trpa-1, has the same deficit in 
chemotaxis as the ocr-1 mutants alone (data not shown). The nicotine chemosensory deficits of 
ocr-1 mutants persisted at all dilutions tested (Fig 3.6). Together, these data suggest that OCR-1 
is necessary for nicotine chemotaxis. 
In nearly every chemosensory behavior tested in C. elegans, OSM-9 has a vital, if not 
necessary, role in transducing the chemical signal (Colbert, 1997). In our nicotine chemotaxis 
assay, however, we see that worms lacking OSM-9 are still capable of locating the nicotine 
source. In fact, osm-9 mutants show improved chemotaxis when compared to wild-type worms at 
the 1:50 dilution and this exaggerated nicotine chemotaxis of osm-9 mutants was present at all 
dilutions (Fig 3.7). This would seem to suggest that not only is OSM-9 not necessary for nicotine 
olfaction, but it may actually be detrimental to this behavior.   
In diacetyl olfaction, both OSM-9 and OCR-2 are necessary and their proper localization 
to the sensory cilia depend on one another (Colbert and Bargmann, 1995). Curiously, however, 
ocr-2 mutants have normal nicotine chemotaxis at most dilutions, but show a deficit in 
chemotaxis to the 1:5 and pure nicotine conditions (Fig 3.8). The ocr-1;ocr-2 double mutant, 
however, showed no nicotine chemotaxis at any dilution (Fig 3.9) further demonstrating the 
necessity of ocr-1 in this nicotine chemotaxis.  
Meanwhile, at the 1:50 nicotine dilution, ocr-3, ocr-4, trpa-1 all show a normal nicotine 
chemotaxis phenotype. As ocr-3 appears to be expressed only in rectal glands, we did not 
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explore this gene further. OCR-4 is expressed in the mechanosensory OLQ neurons. On the 
chance the expression pattern for this protein is incomplete and since it does have some neuronal 
expression, we elected to test ocr-4 mutants on a range nicotine dilutions. Similarly, as the 
mammalian TRPA1 is expressed in the nasal airway and can bind nicotine, we decided to test 
these mutants on a full range of nicotine doses. However, we saw no effect on nicotine 
chemotaxis in either trpa-1 or ocr-4 null mutants any of the tested dilutions (Fig 3.10).  
We next attempted to rescue nicotine chemotaxis by expressing OCR-1 cDNA solely in 
neurons. In the ocr-1 mutant background, a transgenic line expressing OCR-1 cDNA behind a 
neuron-specific promoter rescued the nicotine chemotaxis defects of these animals (Fig 3.11). 
Not only is OCR-1 necessary for nicotine olfaction, but its presence in neurons alone restores 
this behavior in ocr-1 null mutants.  
 
Discussion 
 
 Chemosensation in C. elegans is divisible into gustation and olfaction. While worm 
gustation typically detects chemicals in the high micromolar to millimolar concentrations, worm 
olfaction tends to detect chemicals at much lower concentrations, down to the low nanomolar 
concentrations (Bargmann, 2006). As olfaction also detects primarily volatile chemicals as 
opposed to solutes, it is possible that worms use olfaction to locate potential sources of food 
from a distance, and switch to a more gustatory strategy to maximize time spent near an 
abundant food source. In either case, TRP channels —particularly TRPV channels —play a 
critical role in nematode chemosensation (Bargmann, 2006; Bargmann et al., 1993; Colbert and 
Bargmann, 1995; Colbert, 1997; Tobin et al., 2002; Troemel et al., 1997; Troemel et al., 1999).  
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 In the studies presented here, we see wild-type worms can chemotax to a point-source of 
nicotine over a range concentrations. Interestingly, this chemotaxis behavior does not show the 
classic bell-shaped curve one typically expects to see in drug-induced behaviors over a range of 
doses. Rather, the behavioral response is more similar to the phenomenon of a ‘digital cliff’. The 
worm responds until it reaches some lower detection threshold at which point the nicotine elicits 
no response, analogous to the initiation of an action potential in higher-order animals.  
 Typically, one would expect to see a faltering of the behavioral response at higher drug 
concentrations for a number of reasons —a drug make become paralytic or even toxic at high 
concentrations, for example. In the case of psychomotor stimulants in mammals, high drug 
concentrations paradoxically decrease locomotor activity, particularly when measuring 
movement by breaks in an infrared beam-grid as the animal ceases to pace around the testing 
environment but falls to stereotypical stimulant-induced behaviors such as jaw-grinding, 
excessive grooming, paw-treading, or scratching behaviors (Bonasera et al., 2008). In 
nematodes, specifically, high concentrations of nicotine will result in paralysis, as shown 
elsewhere in this manuscript. However, in our olfactory paradigm, even in the ‘pure nicotine’
condition, the nicotine was not allowed enough time to diffuse fully through the medium thereby 
preventing worms from absorbing or accumulating a large enough internal concentration of 
nicotine to experience this paralytic effect. Thus, the wild-type worms do not show the expected 
faltering of behavioral response at these higher doses.  
 The most clear-cut finding we see in these nicotine chemotaxis studies is the necessity of 
ocr-1 gene expression with the neurons for normal chemotaxis to nicotine. The normal nicotine 
olfactory phenotype of odr-3, however, is more remarkable. The odr-3 gene product is necessary 
in a plethora sensory neurons and sensory responses, including gustation, mechanosensation, 
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osmosensation, and nociception as well as olfaction (Bargmann, 2006). It is, therefore, striking 
that the studies we present here suggest no necessary role for odr-3 in nicotine olfaction (data not 
shown). There are two possible, though not mutually exclusive, explanations for this. First, these 
data would seem to suggest that normal nematode nicotine chemotaxis utilizes some other G-
protein signaling pathway. The second possibility is that this nicotine chemotaxis is not a normal 
nematode behavior outside of the laboratory, but at the bench we are able to control the 
environment of the animal in such a way as to unmask a latent effect nicotine can have at these 
TRP channel proteins. In either case, these studies and those that may follow, will shine a light 
on novel therapeutic approaches for nicotine use, because we have potentially identified a non-
canonical nicotine target. This is, perhaps, especially likely as none of the nAChR alpha subunits 
we tested seem to have a role in this behavior. We should note that nAChR alpha subunit 
mutants with an ‘uncoordinated’phenotype that we did not test appear to be expressed in body 
wall muscles or ventral cord motor neurons. No one has reported expression of these subunits in 
sensory neurons or interneurons.  
 While we were unable to detect an involvement for any nAChR alpha subunits, it is 
important to remember that the Sellings-Pereira group identified both acr-5 and acr-15 as 
necessary genes for nicotine chemotaxis in their paradigm (Sellings et al., 2013). It seems that 
the most likely explanation of this discrepancy between the two studies is the placement of the 
nicotine itself. The Sellings-Pereira group placed the nicotine directly on the NGM and allowed 
it diffuse through the medium to construct their concentration gradient. Consequently, the worm 
was able to absorb nicotine through the cuticle, which permitted the drug to work throughout the 
body of the worm. Our lab has already shown that, when worms absorb nicotine through the 
cuticle, the ACR-15 receptors on AVA neurons play a critical role in the nematode locomotor 
! 64!
response (Feng et al., 2006). Additionally, the ACR-5 receptor is expressed on cholinergic 
ventral cord motor neurons (Winnier et al., 1999). It is likely that in worms lacking this receptor, 
these motor neurons would be less active and, consequently, their post-synaptic partners would 
likely up-regulate the surface expression of their own nAChR. This confluence of events would 
result in a stronger paralytic effect at lower nicotine concentrations. Therefore, worms with loss-
of-function acr-5 mutations would have increased difficulty crawling to a point-source of 
nicotine. In our chemotaxis paradigm, however, it is unlikely nicotine had adequate time to 
diffuse through the cuticle fully. As such, our assay did not return a chemotaxis defect for these 
two nAChR mutants.  
Moving forward, we have developed a working model we will use to continue 
investigating this phenomenon. In this model, G-proteins activated through some unknown 
receptor act at TRPV channels to mediate nicotine chemotaxis. Chemotaxis to the full range of 
nicotine is mediated largely through OCR-1 with some small contribution from OCR-2 at higher 
nicotine levels, while OSM-9 contributes to a no-go signal at all concentrations. Consequently, 
in the ocr-1 mutants that lack the necessary OCR-1, we see no nicotine chemotaxis. However, in 
the ocr-2 mutants we still see chemotaxis at the lower nicotine levels mediated through OCR-1 
despite the lack of OCR-2 in these animals. Finally, in animals lacking OSM-9, we see an 
exaggerated nicotine response as they lose the no-go signal. Fig 3.12 summarizes this working 
model. 
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Nicotine Chemotaxis Paradigm 
 
Fig 3.1 illustrates the nicotine chemotaxis paradigm. Worms crawled freely for one hour. At the 
of the hour, we calculated a chemotaxis index (CI) by counting the number of worms within the 
“A”partition less the worms in the “R”partition and dividing that number by the total number of 
worms to leave the start box, marked with the ‘x’: (A-C) ÷(A+C+M) = CI. This yielded a CI 
between +1.00 (absolute attraction) and -1.00 (absolute repulsion) with a score of 0.00 being 
chance.  
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Nicotine Chemotaxis of Wild-Type Nematodes 
Fig 3.2 shows olfactory chemotaxis to 
volatile chemicals. Fig 3.2a shows 
nematodes crawl toward a 1:1000 dilution 
of the volatile diacetyl [Mean: 0.868 ± 
0.0200] significantly more than they do to 
the ethanol vehicle [Mean: 0.043 ± 0.0109] 
[two-tailed t-Test, p < 0.0001]. Fig 3.2b, 
likewise shows the nematode preference for 
a 1:50 dilution of nicotine [Mean: 0.585 ± 
0.0435] over the ethanol vehicle [Mean: 
0.043 ± 0.0090] [two-tailed t-Test, p < 
0.0001]. Fig 3.2c, however shows that, 
while nematodes will chemotax to both 
nicotine and diacetyl, they have a 
significant preference for diacetyl [Mean: 
0.853 ± 0.0210] over nicotine [Mean: 0.552 
± 0.0179] [two-tailed t-Test, p < 0.0001].   
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Wild-Type Nicotine Chemotaxis 
 
Fig 3.3 shows the olfactory chemotaxis to nicotine of wild-type nematodes. While worms are 
unable to chemotax to a 1:500 [Mean: 0.044 ± 0.0263] dilution of nicotine in ethanol, worms in 
the ‘1:100’ [Mean: 0.396 ± 0.0257], ‘1:50’ [Mean: 0.585 ± 0.0355], ‘1:25’ [Mean: 0.379 ± 
0.0563], ‘1:5’ [Mean: 0.330 ± 0.0806], and ‘Pure’ [Mean: 0.371 ± 0.0599] groups all show 
reliable to chemotaxis in comparison to the ‘No Nicotine’[Mean: 0.041 ± 0.0177] group [one-
way ANOVA p < 0.0001, Bonferroni’s MCT].     
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Screen of Acetylcholine Receptor Mutants in Nicotine Chemotaxis 
 
Fig 3.4 shows a screen of strains carrying null mutations in a putative α-subunit of nicotinic 
acetylcholine receptors in the nicotine chemotaxis paradigm. None of the nAChR mutants tested 
showed a deficit in nicotine olfactory chemotaxis [one-way ANOVA p = 0.1630].  
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Screen of TRP Channel Mutants in Nicotine Chemotaxis 
 
Fig 3.5 shows a screen of TRP channel mutants in the nicotine olfaction paradigm. When 
compared to wild-type [Mean: 0.605 ± 0.0249] animals, ocr-2 [Mean: 0.634 ± 0.0474], ocr-3 
[Mean: 0.608 ± 0.0422], ocr-4 [Mean: 0.602 ± 0.0642], and trpa-1 [Mean: 0.629 ± 0.0177] 
showed no defect in nicotine chemotaxis at the 1:50 dilution of nicotine. The osm-9 [Mean: 
0.807 ± 0.0178] mutants showed a significant increase nicotine chemotaxis, while both strains 
carrying either the ok132 [Mean: 0.056 ± 0.0114] or ak46 [Mean: 0.036 ± 0.0249] allele of ocr-1 
showed a significant defect in olfactory nicotine chemotaxis [one-way ANOVA p < 0.0001, 
Dunnett’s MCT].  
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ocr-1 Mutants Nicotine Chemotaxis 
 
Fig 3.6 shows the nicotine chemotaxis response of ocr-1 mutants. Mutants on plates with a 1:100 
[Mean: 0.025 ± 0.0068], 1:50 [Mean: 0.095 ± 0.0450], 1:5 [Mean: 0.109 ± 0.0291], or Pure 
[Mean: 0.066 ± 0.0361] nicotine dilutions showed no difference when compared to animals on a 
plate with no nicotine [Mean: 0.033 ± 0.0136] [one-way ANOVA p = 0.1377].  
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osm-9 Mutants Nicotine Chemotaxis 
 
Fig 3.7 shows the nicotine chemotaxis response of osm-9 mutants. Mutants on plates with a 
1:100 [Mean: 0.422 ± 0.0317], 1:50 [Mean: 0.807 ± 0.0178], 1:5 [Mean: 0.473 ± 0.0486], or 
Pure [Mean: 0.500 ± 0.0289] nicotine dilutions showed significant nicotine chemotaxis when 
compared to animals on a plate with no nicotine [Mean: 0.040 ± 0.0207] [one-way ANOVA p < 
0.0001, Dunnett’s MCT]. While not tested directly, the chemotaxis index at each dilution of 
these mutants appears to be qualitatively more robust than wild-type animals at the same 
dilution.    
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ocr-2 Mutants Nicotine Chemotaxis 
 
Fig 3.8 shows the nicotine chemotaxis response of ocr-2 mutants. When compared to the ‘no 
nicotine’group [Mean: 0.037 ± 0.0173], the ‘1:500’[Mean: 0.053 ± 0.0313], ‘1:5’[Mean: 0.054 
± 0.0308], and ‘Pure’[Mean: 0.041 ± 0.0231] groups show no significant difference, while the 
‘1:100’[Mean: 0.330 ± 0.0830] and ‘1:50’[Mean: 0.630 ± 0.1001] groups each show significant 
chemotaxis to the nicotine source [one-way ANOVA p < 0.0001, Dunnett’s MCT].  
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ocr-1;ocr-2 Double Mutants Nicotine Chemotaxis 
 
Fig 3.9 shows the nicotine chemotaxis response of ocr-1;ocr-2 double mutants. Double Mutants 
on plates with a 1:100 [Mean: 0.033 ± 0.0127], 1:50 [Mean: 0.040 ± 0.0082], 1:5 [Mean: 0.011 ± 
0.0067], or Pure [Mean: 0.023 ± 0.0087] nicotine dilutions showed no difference when compared 
to animals on a plate with no nicotine [Mean: 0.021 ± 0.0066] [one-way ANOVA p = 0.1148].  
Di
ac
ety
l
W
ild
typ
e (
N2
)
No
 N
ico
tin
e
1:1
00 1:5
0 1:5 Pu
re
-0.5
0.0
0.5
1.0
Fig 3.9
n.s.
Nicotine Dilution (in EtOH)
C
he
m
ot
ax
is
 In
de
x
! 74!
Other TRP Channel Mutants Nicotine Chemotaxis 
Fig 3.10 shows the dose ranges of trpa-1 and 
ocr-4 mutants. Fig 3.10a shows the nicotine 
chemotaxis response of trpa-1 mutants. 
Mutants on plates with a 1:100 [Mean: 0.514 
± 0.0201], 1:50 [Mean: 0.660 ± 0.0668], 1:5 
[Mean: 0.454 ± 0.0606], or Pure [Mean: 
0.437 ± 0.0834] nicotine dilutions showed 
significant nicotine chemotaxis when 
compared to animals on a plate with no 
nicotine [Mean: 0.058 ± 0.0326] [one-way 
ANOVA p < 0.0001, Dunnett’s MCT]. Fig 
3.10b shows the nicotine chemotaxis 
response of ocr-4 mutants. Mutants on plates 
with a 1:100 [Mean: 0.446 ± 0.0437], 1:50 
[Mean: 0.604 ± 0.0282], 1:5 [Mean: 0.432 ± 
0.0958], or Pure [Mean: 0.399 ± 0.0613] 
nicotine dilutions showed significant nicotine chemotaxis when compared to animals on a plate 
with no nicotine [Mean: 0.064 ± 0.0280] [one-way ANOVA p < 0.001, Dunnett’s MCT].   
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Rescue of OCR-1 in ocr-1 Mutant Background 
 
Fig 3.11 shows the nicotine chemotaxis of transgenic animals rescuing OCR-1 specifically 
within neurons in an ocr-1 null background. At the 1:50 nicotine dilution, animals carrying a 
transgene to express OCR-1 within neurons [Mean: 0.853 ± 0.0277] show nicotine chemotaxis at 
levels that exceed wild-type animals [Mean: 0.565 ± 0.0482], rescuing the defect in this behavior 
seen in the ocr-1 mutants [Mean: 0.095 ± 0.0450] [one-way ANOVA p < 0.0001, Bonferroni’s 
MCT].  ! !
Di
ac
ety
l (N
2)
W
ild
typ
e (
N2
)
oc
r-1
 (o
k1
32
)
oc
r-1
; O
CR
1
-0.5
0.0
0.5
1.0
*
Fig 3.11
C
he
m
ot
ax
is
 In
de
x
! 76!
Working Model of TRPV-Mediated Nicotine Chemotaxis 
 
Fig!3.12!shows!a!working!model!to!explain!the!role!of!TRPV!proteins!in!nicotine!olfaction.!In!this!model,!nicotine!targets!OCRG1,!either!directly!or!indirectly.!At!low!levels!of!nicotine,!OCRG1!alone!mediates!the!nicotine!chemotaxis!response.!As!nicotine!levels!rise,!the!much!lower!affinity!and!closely!homologous,!OCRG2,!comes!online!to!mediate!part!of!this!nicotine!chemotaxis!at!the!more!pure!nicotine!levels.!
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Chapter IV 
Concluding Remarks 
 
 C. elegans is a simple metazoan organism, but in its simplicity lies its strength as a model 
organism. As an hermaphroditic species capable of self-fertilization that has no need for denning, 
the motivated behaviors of these animals are largely limited to food-seeking and to the avoidance 
of noxious stimuli. This, in conjunction with the tractability of nematode genome and simplicity 
of its nervous system, makes C. elegans a powerful, if unlikely, tool for investigating drug-
responsive behaviors at the molecular and cellular level.   
 A number of research groups, among them our own, have demonstrated the feasibility of 
C. elegans as a model for studying drugs of abuse. Sobkowiak and colleagues, for example, 
demonstrated that nematodes respond to nicotine in both a concentration-dependent and time-
dependent manner (Sobkowiak et al., 2011). As discussed previously, the Sellings-Pereira group 
showed that worms are capable of navigating up a nicotine gradient (Sellings et al., 2013). 
Musselman and colleagues, furthermore, have used nicotine paired with salts to probe CS-US 
associations in nematodes (Musselman et al., 2012). Our lab, meanwhile, has shown that worms 
respond to an acute nicotine challenge with an increase in crawl speed that is dependent upon 
TRP channels (Feng et al., 2006). Additionally, our lab has also shown that acute cocaine can 
also elicit a hypolocomotive behavioral response in C. elegans (Ward et al., 2009). Moreover, 
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Davies and colleagues have done exciting work in identifying genes involved in the nematode 
response to ethanol (Davies and McIntire, 2004).  
 Herein, we present two additional lines of research adding to the growing literature 
supporting C. elegans as model for understanding drugs of abuse more completely. In probing 
the insulin signaling pathway mutants, we sought to explore more deeply the acute nicotine 
response of nematodes and we turned to olfactory chemotaxis identify a novel role for TRP 
channels in a second nicotine response paradigm. We are the first to demonstrate an olfactory 
component to nicotine chemotaxis in C. elegans and no one has yet to report a direct effect of the 
insulin pathway on nicotine-related behaviors.  
 While the field is still evolving, a role for insulin signaling in addiction biology is 
becoming increasingly more obvious. Insulin receptors are enriched within mammalian brain 
regions susceptible to pharmacological effects from drugs of abuse (Daws et al., 2011; Konner et 
al., 2011; Labouebe et al., 2013). Insulin regulates DA transporter activity through an Akt-
dependent pathway (Pardini et al., 2006; Russo et al., 2007; Sugano et al., 2006). This same IIS-
Akt pathway is what we discovered to be crucial in the normal nematode acute nicotine response. 
Moreover, acetylcholine receptors are vital regulators of DA neuron activity in the mammalian 
midbrain (Exley et al., 2008; Exley and Cragg, 2008; Exley et al., 2011; Exley et al., 2012; Faure 
et al., 2014; Picciotto et al., 1998; You et al., 2008). It is clear to see how simultaneous 
disruptions in both these regulators of extracellular DA concentrations could evoke pathology. In 
fact, the various interactions among the insulin signaling pathway, acetylcholine receptors, 
midbrain DA neurons could readily explain the high incidence of co-morbidity among addiction 
moieties and energy homeostasis disorders. At the very least, the continuously increasing 
literature expounding upon these interactions should illustrate the importance of monitoring 
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caloric input/output of individuals undergoing a tobacco cessation or other drug rehabilitation 
program. 
 While TRP channels are best known for their role in sensory systems (Kauer and Gibson, 
2009; Montell, 2001, 2005; Venkatachalam and Montell, 2007; Wescott et al., 2013), they are 
gaining recognition as important players in modulating central responses to drugs of abuse 
(Kauer and Gibson, 2009; Wescott et al., 2013). Of particular interest are the TRPV family 
channels, which are targets of endocannabinoids in mammals (Grueter et al., 2010). Incidentally, 
endocannabinoids appear to mediate the insulin-dependent plasticity of tegmental DA neurons in 
mammals (Labouebe et al., 2013). Despite all of the circumstantial evidence within the literature 
to support interactions among the acetylcholine, insulin, and endovanilloids pathways, it remains 
possible that the inverted, depressant-like response our insulin signaling mutants show in 
response to nicotine could be due to their increased susceptibility to the toxic effects of nicotine, 
despite the fact that they do not appear to succumb to nicotine-induced paralysis any earlier than 
wild-type nematodes. Regardless, even if this interpretation were to prove true, it would still 
support a clinical relevance for monitoring the insulin signaling pathway in current and 
recovering addicts, especially nicotine addicts.  
 Here, however, we described a clearly novel sensory role for the TRPV channel OCR-1 
in C. elegans olfaction. For all previously known volatile chemicals to which nematodes 
respond, one or more G-proteins are necessary to activate a TRP channel (Bargmann, 2006; 
Micale et al., 2010). Nicotine, surprisingly, appears to act directly at OCR-1, bypassing odr-3 
and the G-protein pathway. If nicotine can act directly at TRPV channels, one might be tempted 
to suggest that the smell of vaporized nicotine from smoking tobacco may mediate some of the 
addicting properties of nicotine. However, as roughly 1,000 different chemicals compose 
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cigarette smoke making the smoke a highly complex odorant, this seems unlikely. A number of  
recent studies have suggested that the unconditioned properties of cocaine in the periphery could, 
over time, act as a conditioned stimulus predicting the unconditioned euphoria the drug induces 
(Porter-Stransky et al., 2011; Wise et al., 2008). This seems to be a more plausible effect of 
nicotine activating TRPV channels in the pharynx and nasal mucosa —peripheral, physiological 
effects of nicotine could come to serve as a CS that predicts the central US properties of the drug 
once it reaches the brain.  
More likely still, is a role for TRPV channels acting within the central nervous system to 
modulate or gate the window for associative learning, particularly within the mesolimbic 
dopamine system. As some evidence already implicates the endovanilloids in neural mechanisms 
thought to underlie learning and memory (Grueter et al., 2010; Kauer, 2004; Kauer and Gibson, 
2009; Labouebe et al., 2013), plumbing the role of TRPV channels in mammalian motivated 
behaviors and associative learning promises exciting results in the coming years. For example, 
the typically retrograde nature of the endocannabinoids suggests that TPRV channels could play 
a crucial role in terminal control of neurotransmitter release within the nucleus accumbens, 
prefrontal cortex, and amygdala, fine-tuning midbrain dopamine signals or coordinating among 
various neurotransmitter systems to improve the signal-to-noise ratio in the chemical 
communication of the brain. In addition, overwhelming evidence already demonstrates that 
various TRP channels pair with metabotropic glutamate receptors (Bengtson et al., 2004; Berg et 
al., 2007; Fowler et al., 2007; Grueter et al., 2010; Huang et al., 2007; Huang et al., 2011; Kim et 
al., 2003; Musella et al., 2010; Riccio et al., 2009). It could be most exciting to learn that some 
monoamine GPCRs can physically or functionally couple with TRP channels to stabilize the 
window of time necessary for coincidence detection and synaptic plasticity. Furthermore, as yet, 
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very little work has examined the role of TRP channels in these underdogs of synaptic 
physiology and addiction. In any case, the effects of TRP channels already identified in the 
mesolimbic dopamine system make them a compelling target for an adjunct pharmacotherapy in 
tobacco cessation programs.  
As we continue to explore C. elegans as a model for addiction-related behaviors, it will 
be interesting to see how hard they will work to reach a point-source of nicotine. For example, 
nematodes avoid crossing copper-containing regions of their environment. Perhaps worms 
previously exposed to nicotine would be more willing to cross a copper barrier to reach a 
nicotine source than their drug-na ve controls. This would be commensurate with a human, or 
rodent model organism, who continues drug-seeking despite negative consequences. More 
interesting still, would be if TRPV channel mutants then failed to show this behavior. With 
regard to the insulin findings presented here, a number of questions still remain. It would be 
useful to identify the exact neuron or neurons in which daf-2/IIS signaling modulates changes in 
locomotion following nicotine exposure. Additionally, identifying which gene or genes that daf-
16/FoxO regulate in response to nicotine could help to discover novel targets in human nicotine 
dependence treatment. Furthermore, as Akt activity also regulates the mTOR pathway, there 
exists an entire avenue of study yet to pursue in nematodes. Both of these lines of research  the 
interactions between insulin signaling and drugs of abuse as well as the role of TRP channels in 
addiction biology  promise to yield exciting results in the years to come.  !  
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